<!DOCTYPE html>
<html style="overflow: hidden;">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">


<meta name="wpd_version" content="0.2">
<meta name="wpd_baseurl" content="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/article/pii/S138665320300115X?np=y">
<meta name="wpd_url" content="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/article/pii/S138665320300115X?np=y">
<meta name="wpd_date" content="2013-04-17T11:12Z">
<script async="async" type="text/javascript">s_c_il[1].cdw=s_c_il[1].d.write;s_c_il[1].cdwb="";s_c_il[1].d.write=function(m){s_c_il[1].cdwb+=m};
s.channel="publications";
s.pageName="article";
if (typeof (SDM) != 'undefined') {
  if (typeof(SDM.pageType) != 'undefined' &&
      typeof(SDM.issn_or_isbn) != 'undefined' &&
      typeof(SDM.pm) != 'undefined' &&
      typeof(SDM.pm.pii) != 'undefined' &&
      typeof(SDM.pm.contentType) != 'undefined') {
      var ct=SDM.pm.contentType.toLowerCase();
      if (ct=="jl") {
        s.prop1="journal";
      } else if (ct=="bk") {
         s.prop1="book";
      } else if (ct=="rw") {
          s.prop1="refwork";
      } else if (ct=="bs") {
          s.prop1="bookseries";
      } else if (ct=="hb") {
           s.prop1="handbook";
      }
      s.eVar17=SDM.pageType.toLowerCase();
      s.eVar14=SDM.issn_or_isbn; 
      s.eVar28=SDM.issn_or_isbn;
      s.products=";"+SDM.pm.pii;
    }
}
s.events="prodView,event5";
s.prop2=s.prop1;
s.prop4="article";
s_c_il[1].d.write=s_c_il[1].cdw;s_c_il[1].crl(0,1)</script><script src="sciencedirect.js" async="async" type="text/javascript"></script>
<script src="204774041.js"></script>
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<script> var ts1 = new Date().getTime(); </script>
<!-- static const char articletmpl_sccsId[] = "%W%  %G% %U%  Retrieved: %H% %T%"; -->
<meta name="robots" content="NOARCHIVE">
<meta name="robots" content="noodp">
<meta name="robots" content="noydir">
<link rel="canonical" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/article/pii/S138665320300115X">


<link rel="shortcut icon" href="faviconSD.ico" type="image/x-icon">
<title>

ScienceDirect.com - 

    
        
    
    Journal of Clinical Virology
 - Drug resistance in non-subtype B HIV-1</title>






<script>

if( typeof(ts1) == "undefined" ){ ts1= new Date().getTime(); }
Array.prototype.rt = function(label,ts){this.push( "{lbl:"+label+",ts:"+(ts||ts==0?ts:new Date().getTime())+"}" );}
var prs = [];
prs.rt( "head", ts1 );
function loadPDF(){}
</script>


<!--[if lte IE 7]>
<script src="http://cdn.els-cdn.com/sd/js/json2_131R4.js.min"></script>
<![endif]-->

<link rel="stylesheet" type="text/css" href="S138665320300115X.css" media="all">
</head>
<body style="overflow: hidden;">


<div id="dic_bubble" class="selection_bubble fontSize13 noSelect" style="z-index: 9999; border: 1px solid rgb(74, 174, 222);"></div><script>prs.rt('body_start');</script>
<script>

var refLinkURL = "http://www.sciencedirect.com/science/relLink/ajaxReq?_eid=1-s2.0-S138665320300115X";
var updatedCitedBy = "http://www.sciencedirect.com/science/referenceResolution/ajaxRefResol?_updateCitedBy=";
var refResolvePath = "http://www.sciencedirect.com/science/referenceResolution/ajaxRefResol?_eid=1-s2.0-S138665320300115X&_refCnt=90&_docType=converted-article";

// these variables handle the reference resolution. Please ignore the naming.
// the first variable myMap will hold an associative array of links by bibID
// the second variable myXabsCounts holds the scopus counts.
var myMap = []; // html of links for references.
var myXabsCounts = []; // scopus counts
</script>
<div style="width: 1606px; left: 155px;" class="js" id="header-area">
  <div id="header" class="outerWrapper">
<div style="background-color: rgb(255, 255, 255); position: relative;" class="outerWrapper">
<div id="masthead">

<!-- INSERTS THE TEMPLATE VARIABLES POPULATED FROM DB for SCIVERSE and PRODUCT labels -->

<div class="logoSciVerseBlk"> <a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/" <span="" class="logoSciVerseImg">&nbsp;</a> </div> <div class="logoScienceDirectBlk"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/" title="ScienceDirect -The world's leading full-text scientific database"><span class="logoScienceDirectImg">&nbsp;</span></a></div>

</div>
<div id="suites" class="clearfix" aria-label="SciVerse" role="navigation">
<ul class="suites"><li><a href="http://www.hub.sciverse.com/action/home" title="Hub - SciVerse's integrated search">Hub</a></li><li><a title="ScienceDirect - the world's leading full-text scientific database" class="selected">ScienceDirect</a></li><li><a href="http://www.scopus.com.libgate.library.nuigalway.ie/" title="Scopus - the largest abstract and citation database of research literature and quality web sources">Scopus</a></li><li><a href="http://www.applications.sciverse.com/action/userhome" title=" Applications - SciVerse Applications" class="last">Applications</a></li></ul>
</div>
</div>		

     <!-- if not logged in -->
	   

			

    <div id="login" class="clearfix">
    	<ul>
		<li>
    
      <a href="https://www-sciencedirect-com.libgate.library.nuigalway.ie/science?_ob=RegistrationURL&amp;_method=display&amp;_type=ip&amp;_returnURL=http%3A%2F%2Fwww.sciencedirect.com%2Fsciencenp%3Dy&amp;_acct=C000007922&amp;_version=1&amp;_userid=103680&amp;md5=a003226ccf19a695734972d3bd54db42" target="_top" title="Register a ScienceDirect username and password for using alerts and other personal features">Register</a>
    
  </li>
  <!--top right widget-->
  <li class="login " id="loginPlus"><a href="javascript:LoginBox.flipLogin('loginBox',null);" title="Login to ScienceDirect" class="novisit plus nojs" id="loginPlusScript">Login</a><noscript><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=HomePageURL&_method=userHomePage&_fl=y&_acct=C000007922&_version=1&_urlVersion=0&_userid=103680&md5=0773bdb54cea8075a9f1176d3dba54dc" title="Open the Login Box" class="plus" id="loginPlusNoScript" >Login</a></noscript>
  </li>
           
           <li class="last"><a href="http://www.scival.com/" title="Go to SciVal Suite">Go to SciVal Suite</a></li> 
        </ul>
    </div>
    
	<div id="loginBox" style="width: 600px; display: none;">
		
        <div style="width: 285px; float: right; border-left: 1px solid rgb(155, 155, 155); padding-left: 10px; min-height: 180px;">
        
        <div class="sampletext">
        <div style="font-weight: bold; padding-bottom: 5px;">Login via your institution</div>
		
		
		<div><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=FederationURL&amp;_method=display&amp;_type=f&amp;prevURL=http%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS138665320300115X%3Fnp%3Dy&amp;_acct=C000007922&amp;_version=1&amp;_userid=103680&amp;md5=f3508a614debf1e80eb4d8a0d8308a63" title="Go to Athens/ Institution login">Athens / Institution login</a></div>
		
        </div>
	
				
		
                  
                
            
            
        </div>
		
        <div class="padding" style="width: 285px;">
            <form name="sdLogin" method="POST" action="https://www-sciencedirect-com.libgate.library.nuigalway.ie/science/login" id="login-box-form" style="margin: 0px;">
            <b><span style="text-align: right; font-weight: bold;">Login using your SciVerse credentials</span></b>
			<input name="login" value="login" type="hidden">
            <div style="margin-top: 20px;">
            <label for="username"><span style="text-align: right;">Username:</span>
            <input id="username" name="userid" title="Please enter your username here" type="text"></label>
            </div>
            
            <div style="margin-top: 7px;">
            <label for="password"><span style="text-align: right;">Password:</span>
            <input id="password" name="password" maxlength="20" title="Please enter your password here" onkeypress="if(13==event.keyCode)this.form.submit();if (13==event.keyCode)return false;" type="password"></label>
            </div>
                   
                       
			
			<div class="remember">
			<input checked="" name="rememberid" id="rememberMe" value="Y" class="allCheck top2fix" title="Checking this option will log you in automatically next time you visit ScienceDirect" type="checkbox">
			<label for="rememberMe" title="Checking this option will log you in automatically next time you visit ScienceDirect">Remember me</label>
			</div>
            
			<input name="_ob" value="MiamiLogonURL" type="hidden">
			<input name="targetURL" value="http://www.sciencedirect.com/science/article/pii/S138665320300115X?np=y" type="hidden">
			<input name="returnURL" value="http://www.sciencedirect.com/science/article/pii/S138665320300115X?np=y" type="hidden">
            <div class="submit">
			
			<div style="float: left; padding-left: 0px;"><input class="button" name="arrow" alt="Login to ScienceDirect" title="Login to ScienceDirect" value="Login" type="Submit"></div>
        
			
			<div class="notRegistered"><span class="astPad">| </span><span><a href="https://www-sciencedirect-com.libgate.library.nuigalway.ie/science?_ob=RegistrationURL&amp;_method=display&amp;_type=ip&amp;_returnURL=http%3A%2F%2Fwww.sciencedirect.com%2Fsciencenp%3Dy&amp;_acct=C000007922&amp;_version=1&amp;_userid=103680&amp;md5=a003226ccf19a695734972d3bd54db42" title="" target="_top">Not Registered?</a></span></div>
			
			
			<div style="clear: left;"></div>
            </div>
			
            <div class="forgotpass">
			<a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=ReminderURL&amp;_method=display&amp;_acct=C000007922&amp;_version=1&amp;_userid=103680&amp;md5=d42879e2c3ee578ec4edb1badc8cf513" target="passwd" onclick="var remindWin;remindWin=window.open('','passwd','scrollbars=yes,resizable=yes,directories=no,toolbar=n,menubar=no,status=no,width=650,height=300');" title="Click here for help in recovering your ScienceDirect access">Forgotten username or password?</a>
            </div>
            </form>
        </div>
	</div>

	<!-- logged in -->
	     



<div id="navigationTop" class="clearfix" aria-label="ScienceDirect" role="navigation">
    <ul class="nav main">
        <li class="last">
            <a class=" canonHomeLink" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/" method="userHomePage" btn="Y" zone="TopNavBar" origin="home" target="_top" name="Home" title="Home">Home</a>
        </li>
        <li>
            <!--<h1>-->
            <a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/browse" type="all" auth="y" zone="TopNavBar" origin="article" target="_top" name="Publications" title="Publications">Publications</a>
            <!--</h1>-->
        </li>
        
        <li>
            <a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=MiamiSearchURL&amp;_method=requestForm&amp;_btn=Y&amp;_zone=TopNavBar&amp;_origin=article&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=1&amp;_userid=103680&amp;md5=6f00b17e70582bccfd79c0043e2d7e9d" target="_top" name="Search" title="Search">Search</a>
        </li>
        
        
        <li>
            <a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=UserSubscriptionURL&amp;_method=begin&amp;_btn=Y&amp;_zone=TopNavBar&amp;_origin=article&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=1&amp;_userid=103680&amp;md5=8246689b76c81456079cab859fc0613c" target="_top" name="account" title="My settings">My settings</a>
        </li>
        
        
        
        <li>
            <a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=MiamiSDIURL&amp;_method=listAlerts&amp;_btn=Y&amp;_zone=TopNavBar&amp;_origin=article&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=0&amp;_userid=103680&amp;md5=7614e1367f59f6ad24497b7cb1295fc7" target="_top" name="alert" title="Alerts">My alerts</a>
        </li>
        
        
    </ul>
    <ul class="nav misc">
        <li><span id="ChatHeader"></span></li>          
        <li class="last" style="margin-right: 247px;"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=HelpURL&amp;_file=browse_open_doc.htm&amp;_btn=Y&amp;_zone=TopNavBar&amp;_origin=article&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=0&amp;_userid=103680&amp;md5=3078a5cf677d428f5de42e4c8b948657" target="sdhelp" title="Help (Opens new window)" onclick="var helpWin; helpWin=window.open('http://www.sciencedirect.com/science?_ob=HelpURL&amp;_file=browse_open_doc.htm&amp;_btn=Y&amp;_zone=TopNavBar&amp;_origin=article&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=0&amp;_userid=103680&amp;md5=3078a5cf677d428f5de42e4c8b948657','sdhelp','scrollbars=yes,resizable=yes,directories=no,toolbar=no,menubar=no,status=no,width=760,height=570'); helpWin.focus(); return false">Help</a></li>      
    </ul> 
    
                
        <div id="bannerTop">                
            <div>Brought to you by:<br>
            
                <a href="http://www.library.nuigalway.ie.libgate.library.nuigalway.ie/" onclick="openNS('http://www.library.nuigalway.ie'); return false;">James Hardiman Library</a>
            
            </div>
        </div>
        
               
</div>

</div>


</div>













<div style="top: 102px; width: 1606px; left: 155px; bottom: 0px;" class="js" id="page-area">
  <div style="width: 1606px;" class="js" id="articleToolbar">
    <div id="articleNav">
  <ul aria-label="Article options" role="navigation">
    <li>
      <!-- return to gateway -->
       
      
    </li>





<li>
      <div class="icon_exportarticlesci_dir" title="Export citation">
        <div class="icon"></div>
        <a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=DownloadURL&amp;_method=confirm&amp;_eidkey=1-s2.0-S138665320300115X&amp;count=1&amp;_docType=FLA&amp;zone=toolbar&amp;_acct=C000007922&amp;_version=1&amp;_userid=103680&amp;md5=7d33964ea481abc7383e5edb0de128b6">Export citation</a>
      </div>
</li>
  




<li>
  <div class="icon_pdf">
    <div class="icon"></div>
    <a id="pdfLink" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=MiamiImageURL&amp;_cid=271981&amp;_user=103680&amp;_pii=S138665320300115X&amp;_check=y&amp;_origin=article&amp;_zone=toolbar&amp;_coverDate=2004-Mar-31&amp;view=c&amp;originContentFamily=serial&amp;wchp=dGLbVlS-zSkzV&amp;md5=b457c3927fdc15cf55f00d3810b7a029&amp;pid=1-s2.0-S138665320300115X-main.pdf" target="newPdfWin" pdfurl="http://www.sciencedirect.com/science?_ob=MiamiImageURL&amp;_cid=271981&amp;_user=103680&amp;_pii=S138665320300115X&amp;_check=y&amp;_origin=article&amp;_zone=toolbar&amp;_coverDate=2004-Mar-31&amp;view=c&amp;originContentFamily=serial&amp;wchp=dGLbVlS-zSkzV&amp;md5=b457c3927fdc15cf55f00d3810b7a029&amp;pid=1-s2.0-S138665320300115X-main.pdf" class="big pdf ext_sdlink" style="cursor: pointer;" title="Download PDF">PDF  (221 K)</a>
  </div>
</li>
 
 



<li class="optionsPos">
      <div id="moreOptionsButton" title="Show article options">
        <a href="#">More options...</a>
        <div class="down_sci_dir"></div>
      </div>

<!-- More Options Starts-->
<div id="moreOptionsMenu" class="articleOptions articleOptionssci_dir">
<ul class="menuContent">


    
    <li>
    <ul class="ereader">
        <li class="title">

            eReader format &nbsp;<a title="Help" onclick="var help; help=window.open('http://www.sciencedirect.com/science/help');">What's this?</a>
        </li>
        <li>
            <a id="epubLink" class="erLink" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/article/pii/S138665320300115X?np=y" title="ePub">
                <span class="icon epub">&nbsp;</span><span class="ereadertext">ePub</span>
            </a>
        </li>
        <li>
            <a id="mobiLink" class="erLink" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/article/pii/S138665320300115X?np=y" title="Mobipocket">
                <span class="icon mobi">&nbsp;</span><span class="ereadertext">Mobipocket</span>
            </a>
        </li>
    </ul>
    </li>
    





<li>
    <div class="emailsci_dir">
        <div></div>
        <a title="Email this article" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=EmailFriendURL&amp;_method=gatherInfo&amp;refSource=html&amp;count=1&amp;_eidkey=1-s2.0-S138665320300115X&amp;_acct=C000007922&amp;_version=1&amp;_userid=103680&amp;md5=a63498581f65bb2d967ffeaa12c78e4e">Email article</a>
    </div>
</li>

  




   
       <li>
          <div id="alertOn" style="display: none;" class="alertsci_dir">
            <div></div>
            <span>

            Signed up for journal alerts&nbsp;[<a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=PublicationURL&amp;newIssueAlert=2&amp;_cid=271981&amp;_pubType=J&amp;_auth=y&amp;originContentFamily=serial&amp;_pii=S138665320300115X&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=0&amp;_userid=103680&amp;md5=88ed4a23976ddcfdd98c4f683eed4cce">remove</a>]</span>
          </div>
          <div id="alertOff" style="display: inline;" class="alertsci_dir">
            <div></div>
            <a title="Set new Volumes / Issues alert" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=PublicationURL&amp;newIssueAlert=2&amp;_cid=271981&amp;_pubType=J&amp;_auth=y&amp;originContentFamily=serial&amp;_pii=S138665320300115X&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=0&amp;_userid=103680&amp;md5=88ed4a23976ddcfdd98c4f683eed4cce">

            Alert me about new articles in this journal
            </a>
          </div>
          <div id="rsltInd" style="display: none;">
            <div class="imgIcon"><h3><img src="errorIcon.gif" alt="Failure" title="Failure"></h3></div>
            <div class="confirmMsgText">Your selection(s) could not be saved due to an internal error. Please try again.</div>
          </div>          
      </li>
    


<li>
    <div class="thumbnailsci_dir">
        <div></div>
        <a href="javascript:void(0);" id="optImgToggle" title="">Show thumbnail images</a>
    </div>
</li>

</ul>
<div id="articleOptionsAd" role="banner" class="ad"></div>
</div>
<!-- More options Ends -->
</li>
<li id="erToolbar"></li>




</ul>
</div>

<div class="sdSearch" aria-label="Quick search" role="search">
    <fieldset>
        <div class="left">
            <input style="color: rgb(155, 155, 155);" id="quickSearch" name="quickSearch" value="Search ScienceDirect" size="30" maxlength="450" title="Perform a quick search on ScienceDirect" type="text"><button class="submit" title="Submit quick search">Search</button>
        </div>
        <div id="quickSearchButton" class="right" title="Show more quick search options">
            <div class="down_sci_dir"></div>
        </div>
    </fieldset>
</div>
<div class="clear"></div>
<div style="width: 1579px;" class="quickSearch" id="sdQuickSearch" aria-label="Extended search" role="search">
<div class="extSearch" role="search" aria-label="Quick Search">


<form name="qkSrch" method="get" target="_top" action="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science" style="margin: 0px;">
<input name="_ob" value="QuickSearchURL" type="hidden">
<input name="_method" value="submitForm" type="hidden">
<input name="_acct" value="C000007922" type="hidden">
<input name="_origin" value="article" type="hidden">
<input name="_zone" value="qSearch" type="hidden">
<input name="md5" value="150d94845014a5f578fff24e6f5ff0a9" type="hidden">

<table style="margin: 0px;" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr valign="middle">

<!-- JS enabled. Code for Articles -->

<td align="center" nowrap="nowrap">
<label for="Articles" style="cursor: pointer; padding-right: 0px; margin-left: 2px;" class="nojs">Articles</label>
<input class="qsRadio nojs" name="searchtype" id="Articles" value="a" checked="checked" style="" type="radio">
<noscript>

<!-- JS disabled. Code for Articles -->
<span style="margin-left:13px;">Articles</span>
</noscript>
</td>


<!-- Code related for toggling labels -->


<td align="right"><label for="qs_all" id="fieldLabel">&nbsp;&nbsp;&nbsp;&nbsp;All fields</label></td>
<td align="left"><input class="textbox qsinput xpstyle qsImgBlurFocus" name="qs_all" id="qs_all" value="" size="30" maxlength="450" title="For example: heart attack AND behavior?" type="text"></td>




<td align="right"><label for="qs_author">&nbsp;&nbsp;&nbsp;&nbsp;Author</label></td>
<td colspan="5" align="left"><input class="textbox qsinput xpstyle" name="qs_author" id="qs_author" value="" size="33" maxlength="450" title="e.g. J S Smith or John Smith or Smith JS" style="_width:100%" type="text"></td>
<td nowrap="nowrap">

</td><td></td><td></td>
<td align="right" nowrap="nowrap" valign="middle" width="90%">
<a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=MiamiSearchURL&amp;_method=requestForm&amp;_btn=Y&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=1&amp;_userid=103680&amp;md5=36be44d02ea7cffa13df23aca528620a" style="vertical-align: bottom; font-size: 0.92em;">Advanced search</a>
</td>
</tr>
<tr>

<!-- JS enabled. Code for images -->

<td align="center" nowrap="nowrap">
<label for="Images" style="cursor: pointer; padding-right: 0px;" class="nojs">Images</label>
<input class="qsRadio nojs" name="searchtype" id="Images" value="i" type="radio">
<noscript>

<!-- JS disabled. Code for Images -->
<span style="margin-left:13px;"><a href="/science?np=y&imgSel=Y" >Images</a></span>
</noscript>
</td>


<td align="right"><label for="qs_title">&nbsp;&nbsp;&nbsp;&nbsp;Journal/Book&nbsp;title</label></td>
<td align="left"><input autocomplete="off" class="textbox qsinput xpstyle ui-autocomplete-input" id="qs_title" name="qs_title" value="" size="30" maxlength="450" title="For example: journal of molecular biology" type="text"><span class="ui-helper-hidden-accessible" aria-live="polite" role="status"></span></td>


<td class="toggleQukSrch2" align="right"><label for="qs_vol" id="volField">&nbsp;&nbsp;&nbsp;&nbsp;Volume</label></td>
<td class="toggleQukSrch" align="left"><input class="textbox qsinput xpstyle" name="qs_vol" id="qs_vol" value="" size="3" maxlength="10" style="width: 30px;" type="text"></td>
<td class="toggleQukSrch2" align="right"><label for="qs_issue" id="issueField">&nbsp;&nbsp;Issue</label></td>
<td class="toggleQukSrch" align="left"><input class="textbox qsinput xpstyle" name="qs_issue" id="qs_issue" value="" size="3" maxlength="10" style="width: 30px;" type="text"></td>
<td class="toggleQukSrch2" align="right"><label for="qs_pages" id="pageField">&nbsp;&nbsp;Page</label></td>
<td class="toggleQukSrch" align="right"><input class="textbox qsinput xpstyle" name="qs_pages" id="qs_pages" value="" size="3" maxlength="10" title="For example: 14-27" style="width: 30px;" type="text"></td>


<td align="right" nowrap="nowrap">
<input class="button" id="submit_search" alt="Submit Quick Search" title="Submit Quick Search" value="Search" name="sdSearch" type="Submit">
</td> 
<td colspan="8" align="right" nowrap="nowrap" valign="bottom">
<a class="icon_qmarkHelpsci_dir" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=HelpURL&amp;_origin=srch_form&amp;_zone=TopNavBar&amp;_file=qs_tips.htm&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=0&amp;_userid=103680&amp;md5=ae1e488939a34c669c24f09774e72b25" target="sdhelp" onmouseover="window.status='Help is Available';return true" onmouseout="window.status='';return true" onclick="var helpWin;helpWin=window.open('http://www.sciencedirect.com/science?_ob=HelpURL&amp;_file=qs_tips.htm&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=0&amp;_userid=103680&amp;md5=426a1ddabd0771203259aa91ecaa495c','sdhelp','scrollbars=yes,resizable=yes,directories=no,toolbar=no,menubar=no,status=no,width=760,height=570');helpWin.focus();return false" style="font-size: 0.92em; padding-right: 0px;">Search tips</a>
</td>
</tr>
</tbody></table>
</form>
</div>



 
</div>

<div style="color: rgb(255, 0, 0); font-weight: bold; border: 0px solid red;">
  
  
  
  
</div>





  </div>
  <div style="clear: both;"></div>
  <div style="margin-top: 26px; left: 3px;" class="js" id="leftCloseBar">
      <div class="closed" title="Open to view article outline"></div>
  </div>
  <div style="top: 26px; left: 3px; width: 258px;" id="leftPane" class="column js" aria-label="table of contents" role="navigation">
  <div class="js" id="leftPaneInner"><div id="olGraphCbBox"><label><input id="outlineGraphicsCheckBox" checked="true" type="checkBox">Show thumbnails in outline</label></div>
    <div data-st="0" style="top: 32px; overflow: hidden; background: none repeat ; 0% rgb(236, 242, 246);" id="outline" class="outline js">
      <script type="text/javascript">

      document.write("<div class='outlineMsg'>Article outline is loading...</div>");
      </script>
      <noscript>

      <div class="infoMsg">
      <div style="float: left; width: 20px; "><img border="0" src="http://cdn.els-cdn.com/sd/alertIcon.gif" valign="top" alt="Alert message"></div>
      <div style="padding-left:25px;">JavaScript is disabled on your browser. 
<div style="padding-top:10px;">
      Please enable JavaScript to use all the features on this page.</div></div>
      </div>
      </noscript>
      <ul style="display: block; background: none repeat ; 0% rgb(236, 242, 246);" id="itemOutline"><li style="margin-right: 15px;"><div id="ol_section_abstract" class="io item h2sec"><a class="tocLink" href="#section_abstract" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">Abstract<br></a></div></li><li style="margin-right: 15px;"><div id="ol_kwd_1" class="io item h2sec"><a class="tocLink" href="#kwd_1" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">Keywords<br></a></div></li><li style="margin-right: 15px;"><div id="ol_kwd_2" class="io item h2sec"><a class="tocLink" href="#kwd_2" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">Abbreviations<br></a></div></li><li style="margin-right: 15px;"><div id="ol_section_lbl1" class="io item h2sec"><a class="tocLink" href="#section_lbl1" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">1. HIV-1 diversity<br></a></div></li><li style="margin-right: 15px;"><div id="ol_FIG1" class="io item h2sec fig"><a class="tocLink" href="#FIG1" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');"><img data-loaded="true" src="1-s2.0-S138665320300115X-gr1.sml" class="smlImgLazyJSB greyImg displayImg" data-smlsrc="http://ars.els-cdn.com/content/image/1-s2.0-S138665320300115X-gr1.sml" data-thumbheight="93"></a></div></li><li style="margin-right: 15px;"><div id="ol_FIG2" class="io item h2sec fig"><a class="tocLink" href="#FIG2" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');"><img data-loaded="true" src="1-s2.0-S138665320300115X-gr2.sml" class="smlImgLazyJSB greyImg displayImg" data-smlsrc="http://ars.els-cdn.com/content/image/1-s2.0-S138665320300115X-gr2.sml" data-thumbheight="82"></a></div></li><li style="margin-right: 15px;"><div id="ol_section_lbl2" class="io item h2sec"><a class="tocLink" href="#section_lbl2" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">2. HIV-1 drug resistance<br></a></div></li><li style="margin-right: 15px;"><div id="ol_section_lbl3" class="io item h2sec"><a class="tocLink" href="#section_lbl3" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">3. HIV-1 drug resistance in untreated individuals<br></a></div></li><li style="margin-right: 15px;"><div id="ol_section_lbl4" class="io item h2sec"><a class="tocLink" href="#section_lbl4" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">4. HIV-1 drug resistance in treated individuals<br></a></div></li><li style="margin-right: 15px;"><div id="ol_FIG3" class="io item h2sec fig"><a class="tocLink" href="#FIG3" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');"><img data-loaded="true" src="1-s2.0-S138665320300115X-gr3.sml" class="smlImgLazyJSB greyImg displayImg" data-smlsrc="http://ars.els-cdn.com/content/image/1-s2.0-S138665320300115X-gr3.sml" data-thumbheight="93"></a></div></li><li style="margin-right: 15px;"><div id="ol_TBL1" class="io item h2sec tbl"><div class="olIcon olIconTbl"></div><a class="tocLink olIcon olIconTbl" href="#TBL1" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial'); ">Table 1</a></div></li><li style="margin-right: 15px;"><div id="ol_section_lbl5" class="io item h2sec"><a class="tocLink" href="#section_lbl5" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">5. Studies in Africa<br></a></div></li><li style="margin-right: 15px;"><div id="ol_section_lbl6" class="io item h2sec"><a class="tocLink" href="#section_lbl6" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">6. Studies in Europe<br></a></div></li><li style="margin-right: 15px;"><div id="ol_section_lbl7" class="io item h2sec"><a class="tocLink" href="#section_lbl7" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">7. Studies in South America and Cuba<br></a></div></li><li style="margin-right: 15px;"><div id="ol_section_lbl8" class="io item h2sec"><a class="tocLink" href="#section_lbl8" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">8. Studies in Israel<br></a></div></li><li style="margin-right: 15px;"><div id="ol_section_lbl9" class="io item h2sec"><a class="tocLink" href="#section_lbl9" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">9. Summary and conclusions<br></a></div></li><li style="margin-right: 15px;"><div id="ol_section_lbl9.1" class="io item h3sec"><a class="tocLink" href="#section_lbl9.1" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">9.1. NRTIs<br></a></div></li><li style="margin-right: 15px;"><div id="ol_section_lbl9.2" class="io item h3sec"><a class="tocLink" href="#section_lbl9.2" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">9.2. NNRTIs<br></a></div></li><li style="margin-right: 15px;"><div id="ol_section_lbl9.3" class="io item h3sec"><a class="tocLink" href="#section_lbl9.3" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">9.3. PIs<br></a></div></li><li style="margin-right: 15px;"><div id="ol_bibl001" class="io item h2sec"><a class="tocLink" href="#bibl001" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">References<br></a></div></li></ul><div style="width: 241px; background: none repeat ; 0% rgb(236, 242, 246);" id="articleLeftAd"></div></div>
      <div id="leftOpenBar">
        <div class="open" title="Open to view article outline"></div>
      </div>
  </div>
  </div>
  <div tabindex="-1" data-st="0" data-dir="u" style="top: 26px; left: 261px;" id="centerPane" class="column js">
    <div id="centerInner" class="centerInner svBigBox js" aria-label="Article" role="main">
      
<script>prs.rt('data_start');</script>
      <div class="authClaim"></div><div class="head"><div class="publisherLogo"><img data-loaded="true" style="display: inline;" alt="" id="pubLogo" class="imgLazyJSB" src="elsevier.gif" data-defaultlogo="/elsevier.gif"><noscript><img alt="" src="http://origin-cdn.els-cdn.com/sd/elsevier.gif"></noscript></div><div class="publicationHead"><div class="title"><a title="Go to Journal of Clinical Virology on SciVerse ScienceDirect" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/journal/13866532" querystr="?zone=centerPane" class="cLink"><span>Journal of Clinical Virology</span></a></div><p class="volIssue"><a title="Go to table of contents for this volume/issue" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/journal/13866532/29/3">Volume 29, Issue 3</a>, March 2004, Pages 152–159</p></div><div class="publicationCover"><a querystr="?zone=publicationLogo" class="cLink" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/journal/13866532/29/3"><img data-loaded="true" style="display: inline;" alt="Cover image" src="S13866532.gif" class="toprightlogo imgLazyJSB" data-publogo="S13866532.gif"><noscript><img alt="Cover image" src="http://origin-ars.els-cdn.com/content/image/S13866532.gif" class="toprightlogo"></noscript></a></div></div><div class="module_topic_paths"></div><h1 class="svTitle" id="">Drug resistance in non-subtype B HIV-1</h1><ul class="authorGroup noCollab" id=""><li><a href="#" class="authorName" id="authname_N325f80a0N53963f80" data-t="a" data-fn="Rami" data-ln="Kantor" data-pos="1">Rami Kantor</a><a title="Corresponding author contact information" href="#COR1" id="bCOR1" class="intra_ref auth_corr"><img data-loaded="true" style="display: inline;" class="imgLazyJSB" alt="Corresponding author contact information" src="REcor.gif" data-inlimg="/entities/REcor.gif"><noscript><img alt="Corresponding author contact information" src="http://origin-cdn.els-cdn.com/sd/entities/REcor.gif"></noscript></a><sup>, </sup><a href="mailto:rkantor@stanford.edu"><img data-loaded="true" style="display: inline;" class="imgLazyJSB" src="REemail.gif" alt="E-mail the corresponding author" data-inlimg="/entities/REemail.gif"><noscript><img src="http://origin-cdn.els-cdn.com/sd/entities/REemail.gif" alt="E-mail the corresponding author"></noscript></a>, </li><li><a href="#" class="authorName" id="authname_N325f80a0N53964010" data-t="a" data-fn="David" data-ln="Katzenstein" data-pos="2">David Katzenstein</a></li></ul><div class="endLine"></div><ul class="affiliation"><li> <span id="">Division of Infectious Diseases, Center for AIDS Research, Stanford University Medical Center, 300 Pasteur Drive, room S-156, Stanford, CA 94305, USA</span></li></ul><!--VALIDHTML--><!--comment--><dl class="articleDates"><dd>Received 28 January 2003</dd><dd>Accepted 4 April 2003</dd><dd>Available online 6 September 2003</dd></dl><!--VALIDHTML--><ul class="articleDoi"><li><a id="ddDoi" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1386-6532(03)00115-X" target="doilink" onclick="var doiWin; doiWin=window.open('http://dx.doi.org/10.1016/S1386-6532(03)00115-X','doilink','scrollbars=yes,resizable=yes,directories=yes,toolbar=yes,menubar=yes,status=yes'); doiWin.focus()">http://dx.doi.org/10.1016/S1386-6532(03)00115-X</a>, <a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/help/doi.htm" target="sdhelp" onmouseover="window.status='Help is Available';return true" onclick="var helpWin; helpWin=window.open('http://www.sciencedirect.com/science/help/doi.htm','sdhelp','scrollbars=yes,resizable=yes,directories=no,toolbar=no,menubar=no,status=no,width=760,height=570'); helpWin.focus()">How to Cite or Link Using DOI</a></li></ul><!--VALIDHTML--><ul class="articleInfo"><li class="permissions" id="permissions"><div class="boxLink"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=outwardLink&amp;_partnerName=936&amp;_eid=1-s2.0-S138665320300115X&amp;_pii=S138665320300115X&amp;_origin=article&amp;_zone=art_page&amp;_targetURL=https%3A%2F%2Fs100.copyright.com%2FAppDispatchServlet%3FpublisherName%3DELS%26contentID%3DS138665320300115X%26orderBeanReset%3Dtrue&amp;_acct=C000007922&amp;_version=1&amp;_userid=103680&amp;md5=8d87be19a6195c13be6ef486ae73e501" rel="nofollow" class="olSpawnWindow" target="outwardLink">Permissions &amp; Reprints</a></div></li></ul><!--VALIDHTML--><div id="ppvPlaceHolder" class="hidden"></div><!--VALIDHTML--><div id="refersToAndreferredToBy"><dl id="referredToBy" class="documentThread"><!--Referred To By--></dl></div><!--VALIDHTML--><hr id="author1"><div class="abstract svAbstract "><h2 class="secHeading" id="section_abstract">Abstract</h2><p id="">Treatment of HIV-1 with antiretroviral therapy may select mutations in the <em>pol</em> gene associated with resistance to reverse transcriptase inhibitors and protease inhibitors. To provide durable clinical benefit, emergence of drug resistance is countered by prescription of alternative drug regimens. Data on sequential treatments that are effective after virologic failure and the selection of drug resistance is largely confined to HIV-1 subtype B, the clade that has circulated in North America and Europe. However, HIV-1 subtype B currently accounts for only 12% of the estimated 40 million HIV infected individuals worldwide. The global HIV-1 epidemic includes infection with nine identified HIV-1 group M subtypes (A–K), as well as distinct sub-subtypes and numerous chimerical or recombinant forms. Increasing access to treatment of HIV-1 in the developing world and increasing non-subtype B infection through travel and migration pose new questions about the susceptibility and response of these diverse HIV-1 viruses to antiretroviral drugs. Here we review HIV diversity and the published literature on drug resistance, comparing the known resistance mutations in individuals infected with subtype B to the growing experience in the treatment of non-subtype B HIV-1 worldwide.</p></div><!--VALIDHTML--><script>prs.rt("abs_end");</script><div id="SD_BA1P" class="sgfNoTitleBar sgfNoGadgetBorder svDoNotLink"></div><!--VALIDHTML--><h2 id="kwd_1">Keywords</h2><ul class="keyword" id=""><li id=""><span id="">HIV-1 subtypes</span>; </li><li id=""><span id="">Non-B</span>; </li><li id=""><span id="">Drug resistance</span></li></ul><!--VALIDHTML--><h2 id="kwd_2">Abbreviations</h2><ul class="keyword" id=""><li id=""><span id="">AIDS</span>, <span id="">acquired immunodeficiency syndrome</span>; </li><li id=""><span id="">CRF</span>, <span id="">circulating recombinant form</span>; </li><li id=""><span id="">FDA</span>, <span id="">Food and Drug Administration</span>; </li><li id=""><span id="">HIV</span>, <span id="">human immunodeficiency virus</span>; </li><li id=""><span id="">HAART</span>, <span id="">highly active antiretroviral therapy</span>; </li><li id=""><span id="">IAS</span>, <span id="">international AIDS society</span>; </li><li id=""><span id="">NNRTI</span>, <span id="">non-nucleoside reverse transcriptase inhibitor</span>; </li><li id=""><span id="">NRTI</span>, <span id="">nucleoside reverse transcriptase inhibitor</span>; </li><li id=""><span id="">PI</span>, <span id="">protease inhibitor</span>; </li><li id=""><span id="">RT</span>, <span id="">reverse transcriptase</span></li></ul><!--VALIDHTML--><hr><h2 class="svArticle" id="section_lbl1">1. HIV-1 diversity</h2><p class="svArticle section" id="">HIV is characterized by a wide range of viral genetic diversity among distinct types, groups and clades (<a href="#BIB42" id="bBIB42" class="intra_ref">Hu et al., 1996</a>, <a href="#BIB57" id="bBIB57" class="intra_ref">McCutchan, 2000</a>, <a href="#BIB62" id="bBIB62" class="intra_ref">Peeters, 2001</a>&nbsp;and&nbsp;<a href="#BIB63" id="bBIB63" class="intra_ref">Peeters and Sharp, 2000</a>). The viruses that cause AIDS are the only known members of the lentivirus family of retroviruses, which infect humans, after undergoing cross species transmission events from non-human primates (<span id="bBIB25"><a href="#BIB25" id="ancbBIB25" class="intra_ref">Fauci and Desrosiers, 1997</a></span>). There are two distinct types of human retroviruses, HIV-1 and HIV-2, and at least 18 distinct simian immunodeficiency viruses that naturally infect different African primates. These viruses are distinguished by their genome organizations and phylogenetic relationships (<span id="bBIB34"><a href="#BIB34" id="ancbBIB34" class="intra_ref">Hahn et al., 2000</a></span>).</p><!--VALIDHTML--><p class="svArticle section" id="">Differences between HIV-1 and HIV-2 are well documented in terms of transmissibility, pathogenesis and pattern of spread (<a href="#BIB17" id="bBIB17" class="intra_ref">De Cock et al., 1993</a>&nbsp;and&nbsp;<a href="#BIB46" id="bBIB46" class="intra_ref">Kanki and De Cock, 1994</a>). HIV-2 was the first human lentiviral infection for which there was sufficient evidence to substantiate its zoonotic origins, from sooty mangabey monkeys (<a href="#BIB13" id="bBIB13" class="intra_ref">Clavel et al., 1986</a>&nbsp;and&nbsp;<a href="#BIB67" id="bBIB67" class="intra_ref">Reeves and Doms, 2002</a>). Similarly, it appears that HIV-1 arose as a consequence of transmission from chimpanzees to humans (<span id="bBIB34"><a href="#BIB34" id="ancbBIB34" class="intra_ref">Hahn et al., 2000</a></span>). Notably, there are very important differences between HIV-1 and HIV-2 isolates with respect to drug susceptibility. Specifically, non-nucleoside reverse transcriptase inhibitors (NNRTIs) are active only against HIV-1 reverse transcriptase (RT), and demonstrate little activity against HIV-2 RT (<a href="#BIB39" id="bBIB39" class="intra_ref">Hizi et al., 1993</a>, <a href="#BIB68" id="bBIB68" class="intra_ref">Ren et al., 2002</a>&nbsp;and&nbsp;<a href="#BIB88" id="bBIB88" class="intra_ref">Yang et al., 1996</a>).</p><!--VALIDHTML--><p class="svArticle section" id="">HIV-1 is the major pathogen responsible for the AIDS pandemic. Further analyses of different strains of HIV-1 from diverse geographical origins, show that isolates can be subdivided into groups, subtypes, sub-subtypes and circulating recombinant forms (CRFs), based on phylogenetic sequence differences.</p><!--VALIDHTML--><p class="svArticle section" id="">Groups refer to distinctive HIV-1 lineages M (for Major), O (for Outlier), and N (for New, or Non-M, Non-O). All of the HIV-1 strains described in the 1980s, and still the vast majority of strains found worldwide, belong to one of these lineages, group M. Group O seems to be endemic to and largely confined to Cameroon and neighboring countries in West Central Africa, where these viruses represent a small minority of HIV-1 strains (<a href="#BIB33" id="bBIB33" class="intra_ref">Gurtler et al., 1994</a>, <a href="#BIB44" id="bBIB44" class="intra_ref">Jaffe and Schochetman, 1998</a>, <a href="#BIB45" id="bBIB45" class="intra_ref">Janssens et al., 1999</a>, <a href="#BIB60" id="bBIB60" class="intra_ref">Nkengasong et al., 1998</a>&nbsp;and&nbsp;<a href="#BIB85" id="bBIB85" class="intra_ref">Vanden et al., 1996</a>). Group N has only recently been identified, and is so far represented by a limited number of isolates from Cameroonian persons (<a href="#BIB27" id="bBIB27" class="intra_ref">Fonjungo et al., 2000</a>&nbsp;and&nbsp;<a href="#BIB79" id="bBIB79" class="intra_ref">Simon et al., 1998</a>).</p><!--VALIDHTML--><p class="svArticle section" id="">Within group M, there is further phylogenetic distinction, which was initially noted in the most variable part of the virus—the envelope glycoproteins—allowing the classification of a limited number of discrete clades or subtypes even within the relatively conserved <em>pol</em> gene (<span id="bFIG1"><a href="#FIG1" id="ancbFIG1" class="intra_ref">Fig. 1</a></span>). The subtypes are approximately equidistantly related, and are distinct from one another across the entire genome ( <a href="#BIB51" id="bBIB51" class="intra_ref">Korber et al., 2000</a>, <a href="#BIB72" id="bBIB72" class="intra_ref">Robertson et al., 2000a</a>&nbsp;and&nbsp;<a href="#BIB73" id="bBIB73" class="intra_ref">Robertson et al., 2000b</a>). There are currently nine accepted subtypes of HIV-1 group M (A–D, F–H, J and K). Within some subtypes further phylogenetic structure can be identified, leading to a classification into subclades (A1 and A2, F1 and F2) ( <a href="#BIB29" id="bBIB29" class="intra_ref">Gao et al., 2001</a>, <a href="#BIB72" id="bBIB72" class="intra_ref">Robertson et al., 2000a</a>, <a href="#BIB73" id="bBIB73" class="intra_ref">Robertson et al., 2000b</a>&nbsp;and&nbsp;<a href="#BIB83" id="bBIB83" class="intra_ref">Triques et al., 2000</a>).</p><!--VALIDHTML--><div class="figTblUpiOuter svArticle" id="figure_FIG1"><div class="
                    textboxdefault
                "><dl class="figure" id="FIG1" data-t="f"><dt class="autoScroll" data-style="height:290px;width:216px;"><a class="figureLink" href="#gr1" title="Full-size image (5 K)"><img style="display: inline;" class="imgLazyJSB figure large" alt="Full-size image (5 K)" src="grey_pxl.gif" data-thumbeid="1-s2.0-S138665320300115X-gr1.sml" data-fulleid="1-s2.0-S138665320300115X-gr1.gif" data-thumbheight="93" data-thumbwidth="69" data-fullheight="290" data-fullwidth="216" border="0" height="290" width="216"><noscript class="figure large" border="0" alt="Full-size image" data-thumbeid="1-s2.0-S138665320300115X-gr1.sml" data-fulleid="1-s2.0-S138665320300115X-gr1.gif"><img class="figure large" border="0" alt="Full-size image (5 K)" src="http://origin-ars.els-cdn.com/content/image/1-s2.0-S138665320300115X-gr1.gif" data-thumbEID="1-s2.0-S138665320300115X-gr1.sml" data-fullEID="1-s2.0-S138665320300115X-gr1.gif"></noscript></a></dt><dd id="labelCaptionFIG1"><p class="caption">Fig. 1.&nbsp;<span id="">HIV-1 diversity. Neighbor-joining tree constructed from <em>pol</em> sequences of 13 reference isolates (Subtype A isolate U455, CRF01_AE isolate U54771, CRF02_AG isolate L39106, Subtype B isolate HXB2, Subtype C isolate C2220, Subtype D isolate NDK, Subtype F isolate 93BR020, Subtype G isolate SE6165, Subtype H isolate 90CR056, Subtype J isolate SE9173c, Subtype K isolate 97EQTB11C, Group N isolate YBF30, Group O isolate AZT70C). The scale bar represents a 10% nucleotide difference. The tree was constructed using the <span class="smallcaps">phylip</span> phylogenetic package (<span id="FIG1bBIB26"><a href="#BIB26" id="ancFIG1bBIB26" class="intra_ref">Felsenstein, 1993</a></span>).<!--Comment--></span><!--caption--></p></dd><dd class="menuButtonLinks"><div class="btnHolder"><a class="menuTitle" href="#">Figure options</a><div class="down_Btn"></div></div><ul class="menuButton"><li><a href="#FIG1" class="viewWS" title="View in workspace">View in workspace</a></li><li><a href="http://origin-ars.els-cdn.com/content/image/1-s2.0-S138665320300115X-gr1.gif" title="View full-size image - Opens in new window">Download full-size image</a></li><li><a class="ppt" title="Download as PowerPoint slide" href="http://services.elsevier.com.libgate.library.nuigalway.ie/SDWebExport/export/figure/S138665320300115X/1-s2.0-S138665320300115X-gr1.sml/ppt">Download as PowerPoint slide</a></li></ul></dd></dl></div></div><!--VALIDHTML--><p class="svArticle section" id="">By 1995 phylogenetic analyses of the HIV-1 full-length genome sequences demonstrated that certain isolates clustered with two or more subtypes, and recombination was identified as an additional source of HIV-1 variation (<a href="#BIB70" id="bBIB70" class="intra_ref">Robertson et al., 1995a</a>, <a href="#BIB71" id="bBIB71" class="intra_ref">Robertson et al., 1995b</a>&nbsp;and&nbsp;<a href="#BIB76" id="bBIB76" class="intra_ref">Salminen et al., 1995</a>). Accumulating global data show that a significant percentage of strains are mosaics of two or more genetic subtypes, often mixtures of the prevalent subtypes circulating in the region. Thus, in addition to distinct subtypes, CRFs are continuously being identified (<span id="bBIB52"><a href="#BIB52" id="ancbBIB52" class="intra_ref">Kuiken et al., 2000</a></span>). The two most common CRFs are CRF01_AE and CRF02_AG, dominant in Southeast Asia and West Africa, respectively.</p><!--VALIDHTML--><p class="svArticle section" id="">According to a recent report by the WHO–UNAIDS Network for HIV Isolation and Characterization (<span id="bBIB61"><a href="#BIB61" id="ancbBIB61" class="intra_ref">Osmanov et al., 2002</a></span>), in the year 2000, most new infections were due to HIV-1 subtype C, which caused 47.2% of all new HIV-1 global infections. Subtype C HIV-1 predominates in Southern Africa, Ethiopia and India. The second most common clade was subtype A, which caused 30% of all new infections, (including CRF01_AE and CRF02_AG). Overall, more than 18% of new infections were attributed to HIV-1 recombinants. Subtype B was responsible for only 12.3% of global infections. It is the predominant subtype in the Western world, although there are increasing numbers of non-subtype B HIV-1 infection in North America and in Western Europe (<span id="bFIG2"><a href="#FIG2" id="ancbFIG2" class="intra_ref">Fig. 2</a></span>) (<a href="#BIB2" id="bBIB2" class="intra_ref">Balotta et al., 2001</a>, <a href="#BIB6" id="bBIB6" class="intra_ref">Boni et al., 1999</a>, <a href="#BIB8" id="bBIB8" class="intra_ref">Brodine et al., 1999</a>, <a href="#BIB16" id="bBIB16" class="intra_ref">Couturier et al., 2000</a>, <a href="#BIB20" id="bBIB20" class="intra_ref">Deroo et al., 2002</a>, <a href="#BIB40" id="bBIB40" class="intra_ref">Holguin et al., 2001</a>, <a href="#BIB43" id="bBIB43" class="intra_ref">Irwin et al., 1997</a>&nbsp;and&nbsp;<a href="#BIB82" id="bBIB82" class="intra_ref">Thomson and Najera, 2001</a>).</p><!--VALIDHTML--><div class="figTblUpiOuter svArticle" id="figure_FIG2"><div class="
                    textboxdefault
                "><dl class="figure" id="FIG2" data-t="f"><dt class="autoScroll" data-style="height:130px;width:198px;"><a class="figureLink" href="#gr2" title="Full-size image (8 K)"><img style="display: inline;" class="imgLazyJSB figure large" alt="Full-size image (8 K)" src="grey_pxl.gif" data-thumbeid="1-s2.0-S138665320300115X-gr2.sml" data-fulleid="1-s2.0-S138665320300115X-gr2.gif" data-thumbheight="82" data-thumbwidth="125" data-fullheight="130" data-fullwidth="198" border="0" height="130" width="198"><noscript class="figure large" border="0" alt="Full-size image" data-thumbeid="1-s2.0-S138665320300115X-gr2.sml" data-fulleid="1-s2.0-S138665320300115X-gr2.gif"><img class="figure large" border="0" alt="Full-size image (8 K)" src="http://origin-ars.els-cdn.com/content/image/1-s2.0-S138665320300115X-gr2.gif" data-thumbEID="1-s2.0-S138665320300115X-gr2.sml" data-fullEID="1-s2.0-S138665320300115X-gr2.gif"></noscript></a></dt><dd id="labelCaptionFIG2"><p class="caption">Fig. 2.&nbsp;<span id="">A pie chart representing global distribution of HIV-1 subtypes in new infections in the year 2000 (<span id="FIG2bBIB61"><a href="#BIB61" id="ancFIG2bBIB61" class="intra_ref">Osmanov et al., 2002</a></span>). Gray pie slices represent non-B subtypes, accounting for 88% of infections. The white pie slice represents subtype B, accounting for 12% of infections. (A) subtype A and CRF01_AE and CRF02_AG; (B) subtype B; (C) subtype C; (D) subtype D; Other- other subtypes and CRFs.<!--Comment--></span><!--caption--></p></dd><dd class="menuButtonLinks"><div class="btnHolder"><a class="menuTitle" href="#">Figure options</a><div class="down_Btn"></div></div><ul class="menuButton"><li><a href="#FIG2" class="viewWS" title="View in workspace">View in workspace</a></li><li><a href="http://origin-ars.els-cdn.com/content/image/1-s2.0-S138665320300115X-gr2.gif" title="View full-size image - Opens in new window">Download full-size image</a></li><li><a class="ppt" title="Download as PowerPoint slide" href="http://services.elsevier.com.libgate.library.nuigalway.ie/SDWebExport/export/figure/S138665320300115X/1-s2.0-S138665320300115X-gr2.sml/ppt">Download as PowerPoint slide</a></li></ul></dd></dl></div></div><!--VALIDHTML--><h2 class="svArticle" id="section_lbl2">2. HIV-1 drug resistance</h2><p class="svArticle section" id="">Current FDA approved antiretroviral medications include 16 drugs targeted against two <em>pol</em> gene enzymes, the RT and protease: seven nucleoside RT inhibitors (NRTIs) (abacavir, didanosine, lamivudine, stavudine, tenofovir, zalcitabine and zidovudine), three NNRTIs (delavirdine, efavirenz, and nevirapine) and six protease inhibitors (PIs) (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir).</p><!--VALIDHTML--><p class="svArticle section" id="">Antiretroviral drug resistance is the major obstacle to durable treatment of HIV-1. Our understanding of drug resistance is largely limited to HIV-1 from those areas of the world where subtype B viruses predominate and antiretroviral therapy has been accessible.</p><!--VALIDHTML--><p class="svArticle section" id="">The development of drug resistance to the NRTIs, NNRTIs and PIs, is both a cause and a result of virologic treatment failure with incomplete virus suppression. The selection of drug resistance poses ongoing challenges to the success of future treatment regimens. An increasing number of studies in subtype B HIV-1 show that the presence of drug resistance before starting a new drug regimen is an independent predictor of virologic response to that regimen (<a href="#BIB19" id="bBIB19" class="intra_ref">DeGruttola et al., 2000</a>, <a href="#BIB35" id="bBIB35" class="intra_ref">Hanna and D'Aquila, 2001</a>&nbsp;and&nbsp;<a href="#BIB36" id="bBIB36" class="intra_ref">Haubrich and Demeter, 2001</a>). In randomized clinical trials, subjects whose physicians have access to drug resistance data, particularly genotypic resistance data, respond better to therapy than control subjects, whose new regimens are crafted without access to the results of these assays (<a href="#BIB4" id="bBIB4" class="intra_ref">Baxter et al., 2000</a>, <a href="#BIB12" id="bBIB12" class="intra_ref">Cingolani et al., 2002</a>, <a href="#BIB15" id="bBIB15" class="intra_ref">Cohen et al., 2002</a>, <a href="#BIB22" id="bBIB22" class="intra_ref">Durant et al., 1999</a>, <a href="#BIB37" id="bBIB37" class="intra_ref">Haubrich et al., 2001</a>, <a href="#BIB58" id="bBIB58" class="intra_ref">Meynard et al., 2002</a>&nbsp;and&nbsp;<a href="#BIB84" id="bBIB84" class="intra_ref">Tural et al., 2002</a>).</p><!--VALIDHTML--><p class="svArticle section" id="">A standardized RT and protease numbering system for HIV-1 drug resistance mutations has been developed, which is used for genotypic interpretations. All sequences are currently compared with a consensus B sequence (<span class="interref" data-locatortype="url"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=externObjLink&amp;_locator=url&amp;_issn=13866532&amp;_origin=article&amp;_zone=art_page&amp;_plusSign=%2B&amp;_targetURL=http%253A%252F%252Fhiv-web.lanl.gov" target="externObjLink" onclick="var newWidth=((window.screen.availWidth*90)/100);var newHeight=((window.screen.availHeight*90)/100);var parms = 'status=yes,location=yes,' + 'scrollbars=yes,resizable=yes,directories=yes,' + 'toolbar=yes,menubar=yes,' + 'width=' + newWidth + ',height=' + newHeight + ',screenX=10,screenY=10';var externalWin; externalWin=window.open('','externObjLink',parms); externalWin.focus()">http://hiv-web.lanl.gov</a></span>). Mutations are represented by a letter indicating the consensus B wild-type amino acid followed by the amino acid residue number, followed by a letter indicating the mutation (e.g. L90M). It is common to label some mutations either primary (or less commonly ‘major’) or secondary (or ‘minor’; <span id="bBIB38"><a href="#BIB38" id="ancbBIB38" class="intra_ref">Hirsch et al., 2000</a></span>). Primary mutations reduce drug susceptibility by themselves whereas secondary mutations reduce drug susceptibility or improve the replicative fitness of isolates with a primary mutation (<span id="bBIB77"><a href="#BIB77" id="ancbBIB77" class="intra_ref">Shafer, 2002</a></span>).</p><!--VALIDHTML--><p class="svArticle section" id="">Several web-accessible sites which review antiretroviral drug resistance include the International AIDS society (IAS) USA (<span class="interref" data-locatortype="url"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=externObjLink&amp;_locator=url&amp;_issn=13866532&amp;_origin=article&amp;_zone=art_page&amp;_plusSign=%2B&amp;_targetURL=http%253A%252F%252Fwww.iasusa.org" target="externObjLink" onclick="var newWidth=((window.screen.availWidth*90)/100);var newHeight=((window.screen.availHeight*90)/100);var parms = 'status=yes,location=yes,' + 'scrollbars=yes,resizable=yes,directories=yes,' + 'toolbar=yes,menubar=yes,' + 'width=' + newWidth + ',height=' + newHeight + ',screenX=10,screenY=10';var externalWin; externalWin=window.open('','externObjLink',parms); externalWin.focus()">http://www.iasusa.org</a></span>); Los Alamos Database (<span class="interref" data-locatortype="url"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=externObjLink&amp;_locator=url&amp;_issn=13866532&amp;_origin=article&amp;_zone=art_page&amp;_plusSign=%2B&amp;_targetURL=http%253A%252F%252Fhiv-web.lanl.gov" target="externObjLink" onclick="var newWidth=((window.screen.availWidth*90)/100);var newHeight=((window.screen.availHeight*90)/100);var parms = 'status=yes,location=yes,' + 'scrollbars=yes,resizable=yes,directories=yes,' + 'toolbar=yes,menubar=yes,' + 'width=' + newWidth + ',height=' + newHeight + ',screenX=10,screenY=10';var externalWin; externalWin=window.open('','externObjLink',parms); externalWin.focus()">http://hiv-web.lanl.gov</a></span>); Stanford HIV Drug Resistance Database (<span class="interref" data-locatortype="url"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=externObjLink&amp;_locator=url&amp;_issn=13866532&amp;_origin=article&amp;_zone=art_page&amp;_plusSign=%2B&amp;_targetURL=http%253A%252F%252Fhivdb.stanford.edu" target="externObjLink" onclick="var newWidth=((window.screen.availWidth*90)/100);var newHeight=((window.screen.availHeight*90)/100);var parms = 'status=yes,location=yes,' + 'scrollbars=yes,resizable=yes,directories=yes,' + 'toolbar=yes,menubar=yes,' + 'width=' + newWidth + ',height=' + newHeight + ',screenX=10,screenY=10';var externalWin; externalWin=window.open('','externObjLink',parms); externalWin.focus()">http://hivdb.stanford.edu</a></span>); and HIV Resistance Web (<span class="interref" data-locatortype="url"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=externObjLink&amp;_locator=url&amp;_issn=13866532&amp;_origin=article&amp;_zone=art_page&amp;_plusSign=%2B&amp;_targetURL=http%253A%252F%252Fwww.hivresistanceweb.com" target="externObjLink" onclick="var newWidth=((window.screen.availWidth*90)/100);var newHeight=((window.screen.availHeight*90)/100);var parms = 'status=yes,location=yes,' + 'scrollbars=yes,resizable=yes,directories=yes,' + 'toolbar=yes,menubar=yes,' + 'width=' + newWidth + ',height=' + newHeight + ',screenX=10,screenY=10';var externalWin; externalWin=window.open('','externObjLink',parms); externalWin.focus()">http://www.hivresistanceweb.com</a></span>). Reviews of HIV-1 RT and protease drug resistance critically examine the accumulating evidence for genotypic resistance of subtype B HIV-1 (<a href="#BIB18" id="bBIB18" class="intra_ref">Deeks, 2001</a>, <a href="#BIB24" id="bBIB24" class="intra_ref">Erickson et al., 1999</a>, <a href="#BIB38" id="bBIB38" class="intra_ref">Hirsch et al., 2000</a>, <a href="#BIB55" id="bBIB55" class="intra_ref">Loveday, 2001</a>, <a href="#BIB59" id="bBIB59" class="intra_ref">Miller, 2001</a>, <a href="#BIB77" id="bBIB77" class="intra_ref">Shafer, 2002</a>, <a href="#BIB78" id="bBIB78" class="intra_ref">Shafer et al., 2000</a>, <a href="#BIB80" id="bBIB80" class="intra_ref">Soriano and de Mendoza, 2002a</a>&nbsp;and&nbsp;<a href="#BIB81" id="bBIB81" class="intra_ref">Soriano and de Mendoza, 2002b</a>).</p><!--VALIDHTML--><h2 class="svArticle" id="section_lbl3">3. HIV-1 drug resistance in untreated individuals</h2><p class="svArticle section" id="">Detection of RT and protease mutations associated with drug resistance in subtype B HIV-1 in individuals who have not been exposed to antiretroviral therapy is thought to result from either transmission from a treated individual, or drug resistant variants that differ from the wild type consensus sequence.</p><!--VALIDHTML--><p class="svArticle section" id="">In the last decade transmission of drug resistant virus has been recognized among HIV-1 subtype B newly infected individuals in the US and Europe (<a href="#BIB5" id="bBIB5" class="intra_ref">Boden et al., 1999</a>, <a href="#BIB8" id="bBIB8" class="intra_ref">Brodine et al., 1999</a>, <a href="#BIB23" id="bBIB23" class="intra_ref">Erice et al., 1993</a>, <a href="#BIB53" id="bBIB53" class="intra_ref">Little et al., 1999</a>, <a href="#BIB54" id="bBIB54" class="intra_ref">Little et al., 2002</a>&nbsp;and&nbsp;<a href="#BIB90" id="bBIB90" class="intra_ref">Yerly et al., 1999</a>). Thus mutations, usually associated only with drug therapy, have been observed in up to 20% of cases of acute and early HIV-1 infection. Moreover, some unique genotypes with intermediate amino acid residues associated with reversion (back-mutation) of resistance mutations to a wild type genotype (e.g. RT T215D/N/S/C/E) in the context of recent transmission are increasingly observed (<a href="#BIB30" id="bBIB30" class="intra_ref">Garcia-Lerma et al., 2001</a>, <a href="#BIB31" id="bBIB31" class="intra_ref">Goudsmit et al., 1997</a>, <a href="#BIB74" id="bBIB74" class="intra_ref">Rubio et al., 1997</a>&nbsp;and&nbsp;<a href="#BIB89" id="bBIB89" class="intra_ref">Yerly et al., 1998</a>). The escalating rates of transmission of drug resistant virus observed in the past few years, coupled with the poorer response to treatment in persons with drug resistant virus, are being considered as a basis for a recommendation that resistance tests should be performed routinely for persons with new HIV infection (<span id="bBIB54"><a href="#BIB54" id="ancbBIB54" class="intra_ref">Little et al., 2002</a></span>).</p><!--VALIDHTML--><p class="svArticle section" id="">In the absence of any drug exposure, RT and protease sequences from B and non-B HIV-1 are polymorphic among about 40% of the first 240 RT amino acids and 30% of the 99 protease amino acids. Some of these amino acid substitutions occur at high rates in non-subtype B viruses at positions associated with drug resistance in subtype B. These include protease positions 10, 20, 36, 63, 71, 77 and 93, and RT positions 69, 75, 98, 106, 118 and 179 (<span id="bBIB49"><a href="#BIB49" id="ancbBIB49" class="intra_ref">Kantor and Katzenstein, 2003</a></span><span id="bBIB41"><a href="#BIB41" id="ancbBIB41" class="intra_ref">Holguin and Soriano, 2002</a></span>).</p><!--VALIDHTML--><p class="svArticle section" id="">Thus mutations at polymorphic and conserved sites that are associated with drug resistance in subtype B HIV-1 are found at high rates in untreated persons infected with non-subtype B HIV-1. As an increasing number of individuals with non-subtype B infection access antiretroviral therapy, these genotypic differences in non-B consensus (wild-type) sequences may result in new drug resistant forms as well as differences in the long-term outcomes of antiretroviral therapy.</p><!--VALIDHTML--><h2 class="svArticle" id="section_lbl4">4. HIV-1 drug resistance in treated individuals</h2><p class="svArticle section" id="">The prevalence of drug resistance mutations in subtype B infected individuals in the United States and Canada may be as high as 78% among treated individuals with detectable levels of HIV-1 RNA (<span id="bBIB69"><a href="#BIB69" id="ancbBIB69" class="intra_ref">Richman et al., 2001</a></span>). There is a growing and extensive literature on sequence data from untreated and treated persons infected with subtype B virus. This has led to increasingly accurate, albeit complex, interpretations of subtype B drug resistance (<span class="interref" data-locatortype="url"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=externObjLink&amp;_locator=url&amp;_issn=13866532&amp;_origin=article&amp;_zone=art_page&amp;_plusSign=%2B&amp;_targetURL=http%253A%252F%252Fwww.aidsinfo.nih.gov" target="externObjLink" onclick="var newWidth=((window.screen.availWidth*90)/100);var newHeight=((window.screen.availHeight*90)/100);var parms = 'status=yes,location=yes,' + 'scrollbars=yes,resizable=yes,directories=yes,' + 'toolbar=yes,menubar=yes,' + 'width=' + newWidth + ',height=' + newHeight + ',screenX=10,screenY=10';var externalWin; externalWin=window.open('','externObjLink',parms); externalWin.focus()">http://www.aidsinfo.nih.gov</a></span>) (<span id="bBIB38"><a href="#BIB38" id="ancbBIB38" class="intra_ref">Hirsch et al., 2000</a></span>). Patterns of mutations arising during virologic failure with specific drugs have become increasingly recognizable making it possible to recommend alternative drugs to treat persons with resistance.</p><!--VALIDHTML--><p class="svArticle section" id="">However, such data are generally not available for non-B subtypes. Frequency and patterns of specific mutations and response to antiretroviral drug therapies have not been characterized. RT and protease sequences from recent publications including 157 non-B infected persons, have been compiled in the Stanford HIV RT and Protease Sequence Database (<span id="bBIB47"><a href="#BIB47" id="ancbBIB47" class="intra_ref">Kantor et al., 2001</a></span>). <span id="bFIG3"><a href="#FIG3" id="ancbFIG3" class="intra_ref">Fig. 3</a></span> shows the frequency of NRTI, NNRTI and PI related drug resistance mutations in these 157 non-B infected persons (including subtypes A, C, D, F, G, H, J, K, CRF01_AE and CRF02_AG) and in 1400 subtype B infected persons, who received antiretroviral therapy. These sequences and the individually associated treatment histories are available on the Stanford Database website (<span class="interref" data-locatortype="url"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=externObjLink&amp;_locator=url&amp;_issn=13866532&amp;_origin=article&amp;_zone=art_page&amp;_plusSign=%2B&amp;_targetURL=http%253A%252F%252Fhivdb.stanford.edu" target="externObjLink" onclick="var newWidth=((window.screen.availWidth*90)/100);var newHeight=((window.screen.availHeight*90)/100);var parms = 'status=yes,location=yes,' + 'scrollbars=yes,resizable=yes,directories=yes,' + 'toolbar=yes,menubar=yes,' + 'width=' + newWidth + ',height=' + newHeight + ',screenX=10,screenY=10';var externalWin; externalWin=window.open('','externObjLink',parms); externalWin.focus()">http://hivdb.stanford.edu</a></span>). Within each subtype, frequencies of observed changes in amino acids are distinguished from the expected residues at each position of the subtype B consensus sequence (<span class="interref" data-locatortype="url"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=externObjLink&amp;_locator=url&amp;_issn=13866532&amp;_origin=article&amp;_zone=art_page&amp;_plusSign=%2B&amp;_targetURL=http%253A%252F%252Fhiv-web.lanl.gov" target="externObjLink" onclick="var newWidth=((window.screen.availWidth*90)/100);var newHeight=((window.screen.availHeight*90)/100);var parms = 'status=yes,location=yes,' + 'scrollbars=yes,resizable=yes,directories=yes,' + 'toolbar=yes,menubar=yes,' + 'width=' + newWidth + ',height=' + newHeight + ',screenX=10,screenY=10';var externalWin; externalWin=window.open('','externObjLink',parms); externalWin.focus()">http://hiv-web.lanl.gov</a></span>).</p><!--VALIDHTML--><div class="figTblUpiOuter svArticle" id="figure_FIG3"><div class="
                    textboxdefault
                "><dl class="figure" id="FIG3" data-t="f"><dt class="autoScroll" data-style="height:268px;width:216px;"><a class="figureLink" href="#gr3" title="Full-size image (7 K)"><img style="display: inline;" class="imgLazyJSB figure large" alt="Full-size image (7 K)" src="grey_pxl.gif" data-thumbeid="1-s2.0-S138665320300115X-gr3.sml" data-fulleid="1-s2.0-S138665320300115X-gr3.gif" data-thumbheight="93" data-thumbwidth="75" data-fullheight="268" data-fullwidth="216" border="0" height="268" width="216"><noscript class="figure large" border="0" alt="Full-size image" data-thumbeid="1-s2.0-S138665320300115X-gr3.sml" data-fulleid="1-s2.0-S138665320300115X-gr3.gif"><img class="figure large" border="0" alt="Full-size image (7 K)" src="http://origin-ars.els-cdn.com/content/image/1-s2.0-S138665320300115X-gr3.gif" data-thumbEID="1-s2.0-S138665320300115X-gr3.sml" data-fullEID="1-s2.0-S138665320300115X-gr3.gif"></noscript></a></dt><dd id="labelCaptionFIG3"><p class="caption">Fig. 3.&nbsp;<span id="">Frequency of mutations at RT and protease positions associated with subtype B drug resistance in isolates from treated persons infected with B and non-subtype B HIV-1 isolates. PI denotes protease inhibitors, NRTI denotes nucleoside RT inhibitors, NNRTI denotes non-nucleoside RT inhibitors. Non-B isolates include 6 and 9 RT and protease subtype A isolates, 9 and 6 subtype C, 30 and 10 subtype D, 15 and 5 subtype F, 5 and 3 subtype G, 3 and 1 subtype H, 2 and 0 subtype J, 7 and 1 subtype K, 30 and 2 CRF01_AE, 19 and 16 CRF02_AG isolates, respectively.<!--Comment--></span><!--caption--></p></dd><dd class="menuButtonLinks"><div class="btnHolder"><a class="menuTitle" href="#">Figure options</a><div class="down_Btn"></div></div><ul class="menuButton"><li><a href="#FIG3" class="viewWS" title="View in workspace">View in workspace</a></li><li><a href="http://origin-ars.els-cdn.com/content/image/1-s2.0-S138665320300115X-gr3.gif" title="View full-size image - Opens in new window">Download full-size image</a></li><li><a class="ppt" title="Download as PowerPoint slide" href="http://services.elsevier.com.libgate.library.nuigalway.ie/SDWebExport/export/figure/S138665320300115X/1-s2.0-S138665320300115X-gr3.sml/ppt">Download as PowerPoint slide</a></li></ul></dd></dl></div></div><!--VALIDHTML--><p class="svArticle section" id="">Higher percentages of drug resistance mutations to NRTIs and PIs and less evidence of resistance to NNRTIs probably reflect the more recent introduction of NNRTIs into clinical care, particularly in developing countries. Some mutations that are associated with drug resistance in subtype B (protease positions 20, 36, 82 and RT position 179) are more common in non-B subtypes. However, even in this relatively small sample of isolates from drug treated non-B infected individuals, mutations are observed at 22/31 (71%) known subtype B RT drug resistance positions (15/18 NRTI and 7/13 NNRTI related positions), and 13/21 (62%) known subtype B protease drug resistance positions.</p><!--VALIDHTML--><p class="svArticle section" id="">A summary of the recently published studies of persons infected with non-B HIV-1 receiving antiretroviral therapy demonstrates the geographic diversity and the relatively small numbers of persons with non-subtype B viruses who have been followed in treatment protocols (<span id="bTBL1"><a href="#TBL1" id="ancbTBL1" class="intra_ref">Table 1</a></span>). For most of these studies sequences and/or treatment history data are not available and thus they are not included in the compilation in <span id="bFIG3"><a href="#FIG3" id="ancbFIG3" class="intra_ref">Fig. 3</a></span>.</p><!--VALIDHTML--><div class="figTblUpiOuter svArticle" id="table_TBL1"><div class="textboxdefault"><dl id="TBL1" data-t="t" class="table " data-label="Table 1"><dd class="lblCap"><p class="caption"><span class="label">Table 1.
        </span>Published studies on drug resistance in persons infected with HIV-1 non-B isolates</p></dd><dd class="table"><table><colgroup><col><col><col><col><col></colgroup><tbody><tr><td rowspan="1" colspan="1">Region</td><td rowspan="1" colspan="1">Country</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1">Main subtypes</td><td rowspan="1" colspan="1">Number of persons</td></tr><tr><td rowspan="1" colspan="1">Africa</td><td rowspan="1" colspan="1">Cote d'Ivoire</td><td rowspan="1" colspan="1"><span id="bBIB1"><a href="#BIB1" id="ancbBIB1" class="intra_ref">Adje et al., 2001</a></span></td><td rowspan="1" colspan="1">A, AG, D, G, H</td><td rowspan="1" colspan="1">68</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">Uganda</td><td rowspan="1" colspan="1"><span id="bBIB87"><a href="#BIB87" id="ancbBIB87" class="intra_ref">Weidle et al., 2002</a></span></td><td rowspan="1" colspan="1">A, C, D</td><td rowspan="1" colspan="1">94</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">Gabon</td><td rowspan="1" colspan="1"><span id="bBIB86"><a href="#BIB86" id="ancbBIB86" class="intra_ref">Vergne et al., 2002</a></span></td><td rowspan="1" colspan="1">A, AG, AE, D, G, H, J</td><td rowspan="1" colspan="1">22</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">Zimbabwe</td><td rowspan="1" colspan="1"><span id="bBIB48"><a href="#BIB48" id="ancbBIB48" class="intra_ref">Kantor et al., 2002</a></span></td><td rowspan="1" colspan="1">C</td><td rowspan="1" colspan="1">21</td></tr><tr><td rowspan="1" colspan="1">Europe</td><td rowspan="1" colspan="1">United Kingdom</td><td rowspan="1" colspan="1"><span id="bBIB3"><a href="#BIB3" id="ancbBIB3" class="intra_ref">Barlow et al., 2001</a></span></td><td rowspan="1" colspan="1">A, C, D, F, G, H</td><td rowspan="1" colspan="1">25</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"><span id="bBIB9"><a href="#BIB9" id="ancbBIB9" class="intra_ref">Cane et al., 2001</a></span></td><td rowspan="1" colspan="1">C</td><td rowspan="1" colspan="1">43</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"><span id="bBIB66"><a href="#BIB66" id="ancbBIB66" class="intra_ref">Pillay et al., 2002</a></span></td><td rowspan="1" colspan="1">A, AG, AE, C, D, F, G, H</td><td rowspan="1" colspan="1">67</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"><span id="bBIB28"><a href="#BIB28" id="ancbBIB28" class="intra_ref">Frater et al., 2001</a></span></td><td rowspan="1" colspan="1">A, C, D</td><td rowspan="1" colspan="1">18</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">Spain</td><td rowspan="1" colspan="1"><a href="#BIB64" id="bBIB64" class="intra_ref">Perez-Alvarez et al., 2001a</a>&nbsp;and&nbsp;<a href="#BIB65" id="bBIB65" class="intra_ref">Perez-Alvarez et al., 2001b</a></td><td rowspan="1" colspan="1">G, BG</td><td rowspan="1" colspan="1">31</td></tr><tr><td rowspan="1" colspan="1">Latin America</td><td rowspan="1" colspan="1">Brazil</td><td rowspan="1" colspan="1"><a href="#BIB10" id="bBIB10" class="intra_ref">Caride et al., 2000</a>&nbsp;and&nbsp;<a href="#BIB11" id="bBIB11" class="intra_ref">Caride et al., 2001</a></td><td rowspan="1" colspan="1">F, A</td><td rowspan="1" colspan="1">5</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">Brazil</td><td rowspan="1" colspan="1"><span id="bBIB7"><a href="#BIB7" id="ancbBIB7" class="intra_ref">Brindeiro et al., 2002</a></span></td><td rowspan="1" colspan="1">A, C, F</td><td rowspan="1" colspan="1">17</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">Cuba</td><td rowspan="1" colspan="1"><span id="bBIB75"><a href="#BIB75" id="ancbBIB75" class="intra_ref">Ruibal-Brunet et al., 2001</a></span></td><td rowspan="1" colspan="1">A, C</td><td rowspan="1" colspan="1">16</td></tr><tr><td rowspan="1" colspan="1">Middle East</td><td rowspan="1" colspan="1">Israel</td><td rowspan="1" colspan="1"><span id="bBIB32"><a href="#BIB32" id="ancbBIB32" class="intra_ref">Grossman et al., 2001</a></span></td><td rowspan="1" colspan="1">C</td><td rowspan="1" colspan="1">73</td></tr></tbody></table></dd><dd><p class="legend">AE denotes CRF01_AE and AG denotes CRF02_AG.</p></dd><dd class="fullsizeTable"><a title="Full-size table - Opens new window" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=MiamiCaptionURL&amp;_method=retrieve&amp;_eid=1-s2.0-S138665320300115X&amp;_image=TBL1&amp;_ba=&amp;_fmt=full&amp;_orig=na&amp;_issn=13866532&amp;_pii=S138665320300115X&amp;_isTablePopup=Y&amp;_acct=C000038940&amp;_version=1&amp;_urlVersion=0&amp;_userid=696791&amp;md5=51a603c07079a51c5ee041333e292144">Full-size table</a></dd><dd class="menuButtonLinks"><div class="btnHolder"><a class="menuTitle" href="#">Table options</a><div class="down_Btn"></div></div><ul class="menuButton"><li><a href="#TBL1" class="viewWS" title="View in workspace">View in workspace</a></li><li><div class="downloadCsv"><a title="Download as CSV" href="#">Download as CSV</a></div></li></ul></dd></dl></div></div><!--VALIDHTML--><h2 class="svArticle" id="section_lbl5">5. Studies in Africa</h2><p class="svArticle section" id="">C. Adje et al. described genotypic and phenotypic data on RT and protease sequences from 68 non-B infected persons from Cote D'Ivoire (<span id="bBIB1"><a href="#BIB1" id="ancbBIB1" class="intra_ref">Adje et al., 2001</a></span>). In this study 57% of persons had at least one RT or protease primary resistance mutation. Possible explanations given for the high prevalence of resistance included suboptimal treatment regimens, interruption in supply of antiretroviral drugs, and poor adherence leading to inadequate suppression and selection of resistance.</p><!--VALIDHTML--><p class="svArticle section" id="">L. Vergne et al. reported on drug resistance in Gabon, in 22 treated and 13 drug naı̈ve persons infected with non-B HIV-1 (<span id="bBIB86"><a href="#BIB86" id="ancbBIB86" class="intra_ref">Vergne et al., 2002</a></span>). In this study 58% of persons treated for a mean of 17.7 months of antiretroviral therapy, had major drug resistance mutations (mostly to NRTIs). The high percentage, similar to the findings in Cote d'Ivoire, was thought to be due to poor access to drugs and limited capacity to deliver highly active antiretroviral therapy (HAART).</p><!--VALIDHTML--><p class="svArticle section" id="">P. Weidle et al. described a pilot program in Uganda, assessing clinical and laboratory information from 94 persons receiving antiretroviral therapy, infected with subtypes A, C and D (<span id="bBIB87"><a href="#BIB87" id="ancbBIB87" class="intra_ref">Weidle et al., 2002</a></span>). The authors tested phenotypic drug resistance in a subset of specimens. Resistance to at least one drug was found in 65% of persons in whom a result was available. Lower resistance rates were seen for persons who have received HAART versus non-HAART regimens.</p><!--VALIDHTML--><p class="svArticle section" id="">We analyzed RT and protease sequences from 21 Zimbabwean persons infected with subtype C who were failing antiretroviral drug therapy (<span id="bBIB48"><a href="#BIB48" id="ancbBIB48" class="intra_ref">Kantor et al., 2002</a></span>). Of the 21 persons, 81% had known drug-resistance mutations. We compared these sequences to RT and protease sequences from untreated persons infected with subtype C, and to RT protease subtype B sequences from treated and untreated persons and identified subtype C specific polymorphisms and candidate drug resistance mutations.</p><!--VALIDHTML--><h2 class="svArticle" id="section_lbl6">6. Studies in Europe</h2><p class="svArticle section" id="">K. Barlow et al. described 25 subjects infected with HIV-1 CRFs, among 118 isolates from non-B infected individuals in the United Kingdom (<span id="bBIB3"><a href="#BIB3" id="ancbBIB3" class="intra_ref">Barlow et al., 2001</a></span>). Overall, there appeared to be no difference in the frequency or distribution of key resistance mutations between persons infected with single subtypes and those with recombinant viruses. Furthermore, there were no obvious subtype-associated differences in the key resistance mutations. Evidence for differences between subtypes was seen in mutations such as protease M36I, which is considered a secondary resistance mutation in subtype B, but is virtually universal among subtype C viruses.</p><!--VALIDHTML--><p class="svArticle section" id="">P. Cane et al. reported on drug resistance in the protease genes of 55 subtype C persons (43 treated and 12 drug naı̈ve) in the United Kingdom (<span id="bBIB9"><a href="#BIB9" id="ancbBIB9" class="intra_ref">Cane et al., 2001</a></span>). Among the 20 persons taking PIs at the time of sampling, 65% had primary protease mutations. The authors noted a high frequency of L90M (a primary protease mutation related to saquinavir, nelfinavir, indinavir and ritonavir), secondary protease mutations at 36 and 93 and a low frequency of D30N (a primary protease mutation related to nelfinavir).</p><!--VALIDHTML--><p class="svArticle section" id="">D. Pillay et al. recently reported on the association between virologic response and HIV-1 subtype in 113 non-B infected children receiving antiretroviral therapy (<span id="bBIB66"><a href="#BIB66" id="ancbBIB66" class="intra_ref">Pillay et al., 2002</a></span>). No differences were observed in the frequency of development of primary resistance mutations (protease positions 30, 90; RT position 184) in B and non-B viruses, however, differences were observed between subtypes in the prevalence of secondary PI-resistance mutations (positions 20, 36, 77).</p><!--VALIDHTML--><p class="svArticle section" id="">A. Frater et al. followed 79 African antiretroviral drug-naı̈ve persons infected with subtypes A, C and D, who were prescribed HAART (<span id="bBIB28"><a href="#BIB28" id="ancbBIB28" class="intra_ref">Frater et al., 2001</a></span>). Of these, 76% had undetectable viral load after 12 months. Analysis of the baseline sequences before antiretroviral therapy and comparison of non-B to B sequences revealed several inter-subtype differences at RT and protease positions, which were not, however, associated with a lack of response to therapy. Sequences from 18 persons who failed antiretroviral therapy were further analyzed. Several known subtype B drug resistance mutations were seen, as well as several new mutations, not known to be related to drug resistance in subtype B.</p><!--VALIDHTML--><p class="svArticle section" id="">L. Perez-Alvarez et al. from Spain published two reports on 31 persons infected with subtype G and with BG recombinants (<a href="#BIB64" id="bBIB64" class="intra_ref">Perez-Alvarez et al., 2001a</a>&nbsp;and&nbsp;<a href="#BIB65" id="bBIB65" class="intra_ref">Perez-Alvarez et al., 2001b</a>). Some of the persons were naı̈ve to drug therapy, and some were treated. In general, a similar frequency of primary RT and protease mutations was observed in B and non-B subtypes. Different frequencies of secondary mutations were seen in some positions (protease positions 36, 46 and RT positions 98, 211).</p><!--VALIDHTML--><h2 class="svArticle" id="section_lbl7">7. Studies in South America and Cuba</h2><p class="svArticle section" id="">E. Caride et al. published two papers from Brazil, evaluating the RT and protease mutations profile for five persons, four of who were infected with subtype F (<a href="#BIB10" id="bBIB10" class="intra_ref">Caride et al., 2000</a>&nbsp;and&nbsp;<a href="#BIB11" id="bBIB11" class="intra_ref">Caride et al., 2001</a>). In the RT, similar genotypic and phenotypic resistance patterns were found. In the protease, different mutation patterns were seen, despite similar drug usage. Primary protease mutations at positions 84 and 90 were not seen in non-B infected persons, and the resistance pathways included mutations at positions 48 and 82. The authors noted several genotypic differences from subtype B, which did not change in vitro drug susceptibility but were thought to lead to the different resistant pathways seen.</p><!--VALIDHTML--><p class="svArticle section" id="">An additional recent Brazilian study by Brindeiro et al. compared genotypic and phenotypic resistance in non-B versus B HIV-1 isolates from children failing antiretroviral therapy (<span id="bBIB7"><a href="#BIB7" id="ancbBIB7" class="intra_ref">Brindeiro et al., 2002</a></span>). They found significant differences among subtypes in the prevalence of secondary protease mutations, reflecting the prevalence of polymorphisms in non-B isolates.</p><!--VALIDHTML--><p class="svArticle section" id="">I. Ruibal-Brunet et al. determined the prevalence of drug resistance and analyzed non-B subtypes in Cuba (<span id="bBIB75"><a href="#BIB75" id="ancbBIB75" class="intra_ref">Ruibal-Brunet et al., 2001</a></span>). In a sample of 103 persons, 76 received drug therapy. Of the treated individuals, 21% were infected with subtypes A and C. Similar profiles of resistance mutations were seen in isolates from B and non-B infected persons.</p><!--VALIDHTML--><h2 class="svArticle" id="section_lbl8">8. Studies in Israel</h2><p class="svArticle section" id="">Z. Grossman et al. compared sequence data from 87 mostly subtype C infected immigrants from Ethiopia, (14 drug naı̈ve) to 78 subtype B infected persons (20 drug naı̈ve) from Israel (<span id="bBIB32"><a href="#BIB32" id="ancbBIB32" class="intra_ref">Grossman et al., 2001</a></span>). Different rates of mutations were found between subtypes both in drug-naı̈ve and in treatment-experienced persons. The protease D30N mutation, which is associated with nelfinavir therapy, and the AZT related RT mutations were noted to occur at lower rates in subtype C infected persons who received these drugs.</p><!--VALIDHTML--><h2 class="svArticle" id="section_lbl9">9. Summary and conclusions</h2><p class="svArticle section" id="">Although HIV-1 subtypes other than B are responsible for most new HIV infections worldwide, virus sequence data is described from a limited number of persons infected with HIV-1 non-B subtypes. Review of publications which examined the response among non-B infected individuals to antiretroviral drugs demonstrates that about 60% of non-B infected persons who fail antiretroviral therapy have genotypic evidence of drug resistance. This figure is comparable with the findings in the US and Canada (<span id="bBIB69"><a href="#BIB69" id="ancbBIB69" class="intra_ref">Richman et al., 2001</a></span>).</p><!--VALIDHTML--><p class="svArticle section" id="">Similar primary drug resistance mutations appear to evolve in the various subtypes. RT and protease polymorphisms in non-B infected untreated individuals, some of which are at drug resistance positions, may result in differences in response to therapy and the selection of drug resistance. Emerging differences in antiretroviral drug resistance to different drug classes in some non-B isolates exist, as summarized below.</p><!--VALIDHTML--><h3 class="svArticle" id="section_lbl9.1">9.1. NRTIs</h3><p class="svArticle section" id="">Although several studies found lower rates of some NRTI resistance mutations in non-B isolates, rates of primary drug resistance mutations appear similar to subtype B. Different mutation patterns may be due to the use of dual nucleoside therapies, which are more widely reported from Southern Africa and other resource limited settings where non-B subtypes predominate. Some of the described subtype specific polymorphisms (RT positions 39, 43, 60, 207, 211) are adjacent to sites related to drug resistance, and may have an effect on drug efficacy and drug resistance evolution.</p><!--VALIDHTML--><h3 class="svArticle" id="section_lbl9.2">9.2. NNRTIs</h3><p class="svArticle section" id="">These drugs have not been widely available in most developing countries until 1999–2000, and are only recently becoming a preferred treatment due to price reduction and ease of administration. There are accruing reports of K103N and additional major NNRTI-related drug resistance mutations in untreated persons (<span id="bBIB14"><a href="#BIB14" id="ancbBIB14" class="intra_ref">Clevenbergh et al., 2002</a></span>). In addition, mutations at RT positions 98 and 179, which are considered secondary NNRTI associated mutations in subtype B, and specific adjacent polymorphisms (RT positions 177 and 178), are frequently identified among drug naı̈ve non-B infected persons. The significance of these mutations needs to be defined.</p><!--VALIDHTML--><h3 class="svArticle" id="section_lbl9.3">9.3. PIs</h3><p class="svArticle section" id="">There is emerging evidence for the existence of different pathways of drug resistance based on subtype, for example the predominance of L90M rather than D30N among persons with non-B infection exposed to nelfinavir. In addition, isoleucine instead of the wild-type valine in the protease 82 position (a site of primary resistance mutation for several PIs) is more prevalent in some non-B isolates and may decrease susceptibility to PIs (<a href="#BIB21" id="bBIB21" class="intra_ref">Descamps et al., 1998</a>, <a href="#BIB50" id="bBIB50" class="intra_ref">Kaplan et al., 1994</a>&nbsp;and&nbsp;<a href="#BIB56" id="bBIB56" class="intra_ref">Maguire et al., 2002</a>). Mutations at secondary subtype B PI-related positions such as 10, 20, 36, 71, 77 and 93 occur at high frequency in non-B viruses. It is not clear whether this may reduce the activity of some PIs, or if this is a basis for the evolution of different primary resistance mutations and cross-resistance.</p><!--VALIDHTML--><p class="svArticle section" id="">In summary, the use of antiretroviral therapy in persons infected with non-B HIV-1 leads to the selection of drug resistance mutations, which are generally similar to those described in subtype B. Use of specific drug regimens in different regions and populations and development of treatment strategies depend on the investigation and understanding of drug resistance in the context of diverse viral subtypes. Many sequences with data on drug doses, duration, adherence and clinical outcomes are needed to analyze these complex patterns of drug resistance in non-B infected individuals. Worldwide collaboration is essential to identify similarities and differences between B and non-B HIV-1, and to optimally interpret non-B sequence data in clinical settings.</p><!--VALIDHTML--><script type="text/javascript">

              prs.rt("ref_start");
            </script><h2 id="bibl001">References</h2><ol class="references"><li id="BIB1" data-t="r"><ul class="reference" id="bibsbref1"><li class="referenceLabel"><a href="#BIB1" class="label intra_ref">Adje et al., 2001</a></li><li class="author">C. Adje, R. Cheingsong, T.H. Roels <em>et al.</em></li><li class="title"><p>High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Cote d'Ivoire</p></li><li class="source"><p>J. Acquir. Immune Defic. Syndr., 26 (2001), pp. 501–506</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref1" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref1'] = new Array();
        </script></li><li id="BIB2" data-t="r"><ul class="reference" id="bibsbref2"><li class="referenceLabel"><a href="#BIB2" class="label intra_ref">Balotta et al., 2001</a></li><li class="author">C. Balotta, G. Facchi, M. Violin <em>et al.</em></li><li class="title"><p>Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences</p></li><li class="source"><p>J. Acquir. Immune Defic. Syndr., 27 (2001), pp. 499–505</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref2" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref2'] = new Array();
        </script></li><li id="BIB3" data-t="r"><ul class="reference" id="bibsbref3"><li class="referenceLabel"><a href="#BIB3" class="label intra_ref">Barlow et al., 2001</a></li><li class="author">K.L. Barlow, I.D. Tatt, P.A. Cane, D. Pillay, J.P. Clewley</li><li class="title"><p>Recombinant strains of HIV type 1 in the United Kingdom</p></li><li class="source"><p>AIDS Res. Hum. Retroviruses, 17 (2001), pp. 467–474</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref3" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref3'] = new Array();
        </script></li><li id="BIB4" data-t="r"><ul class="reference" id="bibsbref4"><li class="referenceLabel"><a href="#BIB4" class="label intra_ref">Baxter et al., 2000</a></li><li class="author">J.D. Baxter, D.L. Mayers, D.N. Wentworth <em>et al.</em></li><li class="title"><p>A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS</p></li><li class="source"><p>AIDS, 14 (2000), pp. F83–F93</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref4" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref4'] = new Array();
        </script></li><li id="BIB5" data-t="r"><ul class="reference" id="bibsbref5"><li class="referenceLabel"><a href="#BIB5" class="label intra_ref">Boden et al., 1999</a></li><li class="author">D. Boden, A. Hurley, L. Zhang <em>et al.</em></li><li class="title"><p>HIV-1 drug resistance in newly infected individuals</p></li><li class="source"><p>J. Am. Med. Assoc., 282 (1999), pp. 1135–1141</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref5" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref5'] = new Array();
        </script></li><li id="BIB6" data-t="r"><ul class="reference" id="bibsbref6"><li class="referenceLabel"><a href="#BIB6" class="label intra_ref">Boni et al., 1999</a></li><li class="author">J. Boni, H. Pyra, M. Gebhardt <em>et al.</em></li><li class="title"><p>High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland</p></li><li class="source"><p>J. Acquir. Immune Defic. Syndr., 22 (1999), pp. 174–179</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref6" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref6'] = new Array();
        </script></li><li id="BIB7" data-t="r"><ul class="reference" id="bibsbref7"><li class="referenceLabel"><a href="#BIB7" class="label intra_ref">Brindeiro et al., 2002</a></li><li class="author">P.A. Brindeiro, R.M. Brindeiro, C. Mortensen <em>et al.</em></li><li class="title"><p>Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy</p></li><li class="source"><p>J. Clin. Microbiol., 40 (2002), pp. 4512–4519</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref7" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref7'] = new Array();
        </script></li><li id="BIB8" data-t="r"><ul class="reference" id="bibsbref8"><li class="referenceLabel"><a href="#BIB8" class="label intra_ref">Brodine et al., 1999</a></li><li class="author">S.K. Brodine, R.A. Shaffer, M.J. Starkey <em>et al.</em></li><li class="title"><p>Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion</p></li><li class="source"><p>Ann. Intern. Med., 131 (1999), pp. 502–506</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref8" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref8'] = new Array();
        </script></li><li id="BIB9" data-t="r"><ul class="reference" id="bibsbref9"><li class="referenceLabel"><a href="#BIB9" class="label intra_ref">Cane et al., 2001</a></li><li class="author">P.A. Cane, A. de Ruiter, P.A. Rice, M. Wiselka, R. Fox, D. Pillay</li><li class="title"><p>Resistance-associated mutations in the human immunodeficiency virus type 1 subtype c protease gene from treated and untreated patients in the United Kingdom</p></li><li class="source"><p>J. Clin. Microbiol., 39 (2001), pp. 2652–2654</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref9" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref9'] = new Array();
        </script></li><li id="BIB10" data-t="r"><ul class="reference" id="bibsbref10"><li class="referenceLabel"><a href="#BIB10" class="label intra_ref">Caride et al., 2000</a></li><li class="author">E. Caride, R. Brindeiro, K. Hertogs <em>et al.</em></li><li class="title"><p>Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART</p></li><li class="source"><p>Virology, 275 (2000), pp. 107–115</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref10" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref10'] = new Array();
        </script></li><li id="BIB11" data-t="r"><ul class="reference" id="bibsbref11"><li class="referenceLabel"><a href="#BIB11" class="label intra_ref">Caride et al., 2001</a></li><li class="author">E. Caride, K. Hertogs, B. Larder <em>et al.</em></li><li class="title"><p>Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART</p></li><li class="source"><p>Virus Genes, 23 (2001), pp. 193–202</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref11" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref11'] = new Array();
        </script></li><li id="BIB12" data-t="r"><ul class="reference" id="bibsbref12"><li class="referenceLabel"><a href="#BIB12" class="label intra_ref">Cingolani et al., 2002</a></li><li class="author">A. Cingolani, A. Antinori, M.G. Rizzo <em>et al.</em></li><li class="title"><p>Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)</p></li><li class="source"><p>AIDS, 16 (2002), pp. 369–379</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref12" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref12'] = new Array();
        </script></li><li id="BIB13" data-t="r"><ul class="reference" id="bibsbref13"><li class="referenceLabel"><a href="#BIB13" class="label intra_ref">Clavel et al., 1986</a></li><li class="author">F. Clavel, D. Guetard, F. Brun-Vezinet <em>et al.</em></li><li class="title"><p>Isolation of a new human retrovirus from West African patients with AIDS</p></li><li class="source"><p>Science, 233 (1986), pp. 343–346</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref13" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref13'] = new Array();
        </script></li><li id="BIB14" data-t="r"><ul class="reference" id="bibsbref14"><li class="referenceLabel"><a href="#BIB14" class="label intra_ref">Clevenbergh et al., 2002</a></li><li class="author">P. Clevenbergh, E. Cua, E. Dam <em>et al.</em></li><li class="title"><p>Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naive HIV- infected patients</p></li><li class="source"><p>HIV Clin. Trials, 3 (2002), pp. 36–44</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref14" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref14'] = new Array();
        </script></li><li id="BIB15" data-t="r"><ul class="reference" id="bibsbref15"><li class="referenceLabel"><a href="#BIB15" class="label intra_ref">Cohen et al., 2002</a></li><li class="author">C.J. Cohen, S. Hunt, M. Sension <em>et al.</em></li><li class="title"><p>A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy</p></li><li class="source"><p>AIDS, 16 (2002), pp. 579–588</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref15" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref15'] = new Array();
        </script></li><li id="BIB16" data-t="r"><ul class="reference" id="bibsbref16"><li class="referenceLabel"><a href="#BIB16" class="label intra_ref">Couturier et al., 2000</a></li><li class="author">E. Couturier, F. Damond, P. Roques <em>et al.</em></li><li class="title"><p>HIV-1 diversity in France, 1996–1998. The AC 11 laboratory network</p></li><li class="source"><p>AIDS, 14 (2000), pp. 289–296</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref16" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref16'] = new Array();
        </script></li><li id="BIB17" data-t="r"><ul class="reference" id="bibsbref17"><li class="referenceLabel"><a href="#BIB17" class="label intra_ref">De Cock et al., 1993</a></li><li class="author">K.M. De Cock, G. Adjorlolo, E. Ekpini <em>et al.</em></li><li class="title"><p>Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic</p></li><li class="source"><p>J. Am. Med. Assoc., 270 (1993), pp. 2083–2086</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref17" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref17'] = new Array();
        </script></li><li id="BIB18" data-t="r"><ul class="reference" id="bibsbref18"><li class="referenceLabel"><a href="#BIB18" class="label intra_ref">Deeks, 2001</a></li><li class="author">S.G. Deeks</li><li class="title"><p>Nonnucleoside reverse transcriptase inhibitor resistance</p></li><li class="source"><p>J. Acquir. Immune Defic. Syndr., 26 (suppl. 1) (2001), pp. S25–S33</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref18" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref18'] = new Array();
        </script></li><li id="BIB19" data-t="r"><ul class="reference" id="bibsbref19"><li class="referenceLabel"><a href="#BIB19" class="label intra_ref">DeGruttola et al., 2000</a></li><li class="author">V. DeGruttola, L. Dix, R. D'Aquila <em>et al.</em></li><li class="title"><p>The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan</p></li><li class="source"><p>Antivir. Ther., 5 (2000), pp. 41–48</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref19" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref19'] = new Array();
        </script></li><li id="BIB20" data-t="r"><ul class="reference" id="bibsbref20"><li class="referenceLabel"><a href="#BIB20" class="label intra_ref">Deroo et al., 2002</a></li><li class="author">S. Deroo, I. Robert, E. Fontaine <em>et al.</em></li><li class="title"><p>HIV-1 subtypes in Luxembourg, 1983–2000</p></li><li class="source"><p>AIDS, 16 (2002), pp. 2461–2467</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref20" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref20'] = new Array();
        </script></li><li id="BIB21" data-t="r"><ul class="reference" id="bibsbref21"><li class="referenceLabel"><a href="#BIB21" class="label intra_ref">Descamps et al., 1998</a></li><li class="author">D. Descamps, C. Apetrei, G. Collin, F. Damond, F. Simon, F. Brun-Vezinet</li><li class="title"><p>Naturally occurring decreased susceptibility of HIV-1 subtype G to protease inhibitors [letter]</p></li><li class="source"><p>AIDS, 12 (1998), pp. 1109–1111</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref21" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref21'] = new Array();
        </script></li><li id="BIB22" data-t="r"><ul class="reference" id="bibsbref22"><li class="referenceLabel"><a href="#BIB22" class="label intra_ref">Durant et al., 1999</a></li><li class="author">J. Durant, P. Clevenbergh, P. Halfon <em>et al.</em></li><li class="title"><p>Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial</p></li><li class="source"><p>Lancet, 353 (1999), pp. 2195–2199</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref22" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref22'] = new Array();
        </script></li><li id="BIB23" data-t="r"><ul class="reference" id="bibsbref23"><li class="referenceLabel"><a href="#BIB23" class="label intra_ref">Erice et al., 1993</a></li><li class="author">A. Erice, D.L. Mayers, D.G. Strike <em>et al.</em></li><li class="title"><p>Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1</p></li><li class="source"><p>New Engl. J. Med., 328 (1993), pp. 1163–1165</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref23" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref23'] = new Array();
        </script></li><li id="BIB24" data-t="r"><ul class="reference" id="bibsbref24"><li class="referenceLabel"><a href="#BIB24" class="label intra_ref">Erickson et al., 1999</a></li><li class="author">J.W. Erickson, S.V. Gulnik, M. Markowitz</li><li class="title"><p>Protease inhibitors: resistance, cross-resistance, fitness and the choice of initial and salvage therapies</p></li><li class="source"><p>AIDS, 13 (Suppl. A) (1999), pp. S189–S204</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref24" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref24'] = new Array();
        </script></li><li id="BIB25" data-t="r"><ul class="reference" id="bibsbref25"><li class="referenceLabel"><a href="#BIB25" class="label intra_ref">Fauci and Desrosiers, 1997</a></li><li class="author">A.S. Fauci, R.C. Desrosiers</li><li class="title"><p>Pathogenesis of HIV and SIV</p></li><li class="source"><p>J.M. Coffin, S.H. Hughes, H.E. Varmus (Eds.), Retroviruses, Cold Spring Harbor Laboratory Press, New York (1997), pp. 587–636</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref25" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref25'] = new Array();
        </script></li><li id="BIB26" data-t="r"><ul class="reference" id="bibsbref26"><li class="referenceLabel"><a href="#BIB26" class="label intra_ref">Felsenstein, 1993</a></li><li class="author">J. Felsenstein</li><li class="source"><p><span class="smallcaps">phylip</span> (Phylogeny Inference Package) Version 3.5University of Washington, Seattle (1993)</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref26" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref26'] = new Array();
        </script></li><li id="BIB27" data-t="r"><ul class="reference" id="bibsbref27"><li class="referenceLabel"><a href="#BIB27" class="label intra_ref">Fonjungo et al., 2000</a></li><li class="author">P.N. Fonjungo, B.C. Dash, E.N. Mpoudi <em>et al.</em></li><li class="title"><p>Molecular screening for HIV-1 group N and simian immunodeficiency virus cpz-like virus infections in Cameroon [letter]</p></li><li class="source"><p>AIDS, 14 (2000), pp. 750–752</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref27" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref27'] = new Array();
        </script></li><li id="BIB28" data-t="r"><ul class="reference" id="bibsbref28"><li class="referenceLabel"><a href="#BIB28" class="label intra_ref">Frater et al., 2001</a></li><li class="author">A.J. Frater, A. Beardall, K. Ariyoshi <em>et al.</em></li><li class="title"><p>Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients</p></li><li class="source"><p>AIDS, 15 (2001), pp. 1493–1502</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref28" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref28'] = new Array();
        </script></li><li id="BIB29" data-t="r"><ul class="reference" id="bibsbref29"><li class="referenceLabel"><a href="#BIB29" class="label intra_ref">Gao et al., 2001</a></li><li class="author">F. Gao, N. Vidal, Y. Li <em>et al.</em></li><li class="title"><p>Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation</p></li><li class="source"><p>AIDS Res. Hum. Retroviruses, 17 (2001), pp. 675–688</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref29" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref29'] = new Array();
        </script></li><li id="BIB30" data-t="r"><ul class="reference" id="bibsbref30"><li class="referenceLabel"><a href="#BIB30" class="label intra_ref">Garcia-Lerma et al., 2001</a></li><li class="author">J.G. Garcia-Lerma, S. Nidtha, K. Blumoff, H. Weinstock, W. Heneine</li><li class="title"><p>Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons</p></li><li class="source"><p>Proc. Natl. Acad. Sci. USA, 98 (2001), pp. 13907–13912</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref30" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref30'] = new Array();
        </script></li><li id="BIB31" data-t="r"><ul class="reference" id="bibsbref31"><li class="referenceLabel"><a href="#BIB31" class="label intra_ref">Goudsmit et al., 1997</a></li><li class="author">J. Goudsmit, R.A. de, R.E. de, B.R. de</li><li class="title"><p>Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215</p></li><li class="source"><p>J. Virol., 71 (1997), pp. 4479–4484</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref31" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref31'] = new Array();
        </script></li><li id="BIB32" data-t="r"><ul class="reference" id="bibsbref32"><li class="referenceLabel"><a href="#BIB32" class="label intra_ref">Grossman et al., 2001</a></li><li class="author">Z. Grossman, N. Vardinon, D. Chemtob <em>et al.</em></li><li class="title"><p>Genotypic variation of HIV-1 reverse transcriptase and protease: comparative analysis of clade C and clade B</p></li><li class="source"><p>AIDS, 15 (2001), pp. 1453–1460</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref32" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref32'] = new Array();
        </script></li><li id="BIB33" data-t="r"><ul class="reference" id="bibsbref33"><li class="referenceLabel"><a href="#BIB33" class="label intra_ref">Gurtler et al., 1994</a></li><li class="author">L.G. Gurtler, P.H. Hauser, J. Eberle <em>et al.</em></li><li class="title"><p>A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon</p></li><li class="source"><p>J. Virol., 68 (1994), pp. 1581–1585</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref33" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref33'] = new Array();
        </script></li><li id="BIB34" data-t="r"><ul class="reference" id="bibsbref34"><li class="referenceLabel"><a href="#BIB34" class="label intra_ref">Hahn et al., 2000</a></li><li class="author">B.H. Hahn, G.M. Shaw, K.M. De Cock, P.M. Sharp</li><li class="title"><p>AIDS as a zoonosis: scientific and public health implications</p></li><li class="source"><p>Science, 287 (2000), pp. 607–614</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref34" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref34'] = new Array();
        </script></li><li id="BIB35" data-t="r"><ul class="reference" id="bibsbref35"><li class="referenceLabel"><a href="#BIB35" class="label intra_ref">Hanna and D'Aquila, 2001</a></li><li class="author">G.J. Hanna, R.T. D'Aquila</li><li class="title"><p>Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy</p></li><li class="source"><p>Clin. Infect. Dis., 32 (2001), pp. 774–782</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref35" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref35'] = new Array();
        </script></li><li id="BIB36" data-t="r"><ul class="reference" id="bibsbref36"><li class="referenceLabel"><a href="#BIB36" class="label intra_ref">Haubrich and Demeter, 2001</a></li><li class="author">R. Haubrich, L. Demeter</li><li class="title"><p>Clinical utility of resistance testing: retrospective and prospective data supporting use and current recommendations</p></li><li class="source"><p>J. Acquir. Immune Defic. Syndr., 26 (suppl. 1) (2001), pp. S51–S59</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref36" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref36'] = new Array();
        </script></li><li id="BIB37" data-t="r"><ul class="reference" id="bibsbref37"><li class="referenceLabel"><a href="#BIB37" class="label intra_ref">Haubrich et al., 2001</a></li><li class="author">R. Haubrich, P. Keiser, C. Kemper <em>et al.</em></li><li class="title"><p>CCTG 575: a randomized, prospective study of phenotype testing versus standard of care for patients failing antiretroviral therapy</p></li><li class="source"><p>Antivir. Ther., 6 (2001), p. 63</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref37" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref37'] = new Array();
        </script></li><li id="BIB38" data-t="r"><ul class="reference" id="bibsbref38"><li class="referenceLabel"><a href="#BIB38" class="label intra_ref">Hirsch et al., 2000</a></li><li class="author">M.S. Hirsch, F. Brun-Vezinet, R.T. D'Aquila <em>et al.</em></li><li class="title"><p>Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society—USA Panel</p></li><li class="source"><p>J. Am. Med. Assoc., 283 (2000), pp. 2417–2426</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref38" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref38'] = new Array();
        </script></li><li id="BIB39" data-t="r"><ul class="reference" id="bibsbref39"><li class="referenceLabel"><a href="#BIB39" class="label intra_ref">Hizi et al., 1993</a></li><li class="author">A. Hizi, R. Tal, M. Shaharabany <em>et al.</em></li><li class="title"><p>Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors</p></li><li class="source"><p>Antimicrob. Agents Chemother., 37 (1993), pp. 1037–1042</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref39" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref39'] = new Array();
        </script></li><li id="BIB40" data-t="r"><ul class="reference" id="bibsbref40"><li class="referenceLabel"><a href="#BIB40" class="label intra_ref">Holguin et al., 2001</a></li><li class="author">A. Holguin, B. Aracil, A. Alvarez, C. Barros, V. Soriano</li><li class="title"><p>Prevalence of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5</p></li><li class="source"><p>J. Clin. Microbiol., 39 (2001), pp. 1850–1854</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref40" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref40'] = new Array();
        </script></li><li id="BIB41" data-t="r"><ul class="reference" id="bibsbref41"><li class="referenceLabel"><a href="#BIB41" class="label intra_ref">Holguin and Soriano, 2002</a></li><li class="author">A. Holguin, V. Soriano</li><li class="title"><p>Resistance to antiretroviral agents in individuals with HIV-1 non-B subtypes</p></li><li class="source"><p>HIV Clin. Trials, 3 (2002), pp. 403–411</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref41" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref41'] = new Array();
        </script></li><li id="BIB42" data-t="r"><ul class="reference" id="bibsbref42"><li class="referenceLabel"><a href="#BIB42" class="label intra_ref">Hu et al., 1996</a></li><li class="author">D.J. Hu, T.J. Dondero, M.A. Rayfield <em>et al.</em></li><li class="title"><p>The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention</p></li><li class="source"><p>J. Am. Med. Assoc., 275 (1996), pp. 210–216</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref42" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref42'] = new Array();
        </script></li><li id="BIB43" data-t="r"><ul class="reference" id="bibsbref43"><li class="referenceLabel"><a href="#BIB43" class="label intra_ref">Irwin et al., 1997</a></li><li class="author">K.L. Irwin, C.P. Pau, D. Lupo <em>et al.</em></li><li class="title"><p>Presence of human immunodeficiency virus (HIV) type 1 subtype A infection in a New York community with high HIV prevalence: a sentinel site for monitoring HIV genetic diversity in North America. Centers for Disease Control and Prevention-Bronx Lebanon HIV Serosurvey Team</p></li><li class="source"><p>J. Infect. Dis., 176 (1997), pp. 1629–1633</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref43" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref43'] = new Array();
        </script></li><li id="BIB44" data-t="r"><ul class="reference" id="bibsbref44"><li class="referenceLabel"><a href="#BIB44" class="label intra_ref">Jaffe and Schochetman, 1998</a></li><li class="author">H.W. Jaffe, G. Schochetman</li><li class="title"><p>Group O human immunodeficiency virus-1 infections</p></li><li class="source"><p>Infect. Dis. Clin. North Am., 12 (1998), pp. 39–46</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref44" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref44'] = new Array();
        </script></li><li id="BIB45" data-t="r"><ul class="reference" id="bibsbref45"><li class="referenceLabel"><a href="#BIB45" class="label intra_ref">Janssens et al., 1999</a></li><li class="author">W. Janssens, L. Heyndrickx, G. Van der Auwera <em>et al.</em></li><li class="title"><p>Interpatient genetic variability of HIV-1 group O</p></li><li class="source"><p>AIDS, 13 (1999), pp. 41–48</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref45" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref45'] = new Array();
        </script></li><li id="BIB46" data-t="r"><ul class="reference" id="bibsbref46"><li class="referenceLabel"><a href="#BIB46" class="label intra_ref">Kanki and De Cock, 1994</a></li><li class="author">P.J. Kanki, K.M. De Cock</li><li class="title"><p>Epidemiology and natural history of HIV-2</p></li><li class="source"><p>AIDS, 8 (Suppl. 1) (1994), pp. S85–S93</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref46" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref46'] = new Array();
        </script></li><li id="BIB47" data-t="r"><ul class="reference" id="bibsbref47"><li class="referenceLabel"><a href="#BIB47" class="label intra_ref">Kantor et al., 2001</a></li><li class="author">R. Kantor, R. Machekano, M.J. Gonzales, B.S. Dupnik, J.M. Schapiro, R.W. Shafer</li><li class="title"><p>Human immunodeficiency virus reverse transcriptase and protease sequence database: an expanded model integrating natural language text and sequence analysis</p></li><li class="source"><p>Nucleic Acids Res., 29 (2001), pp. 296–299</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref47" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref47'] = new Array();
        </script></li><li id="BIB48" data-t="r"><ul class="reference" id="bibsbref48"><li class="referenceLabel"><a href="#BIB48" class="label intra_ref">Kantor et al., 2002</a></li><li class="author">R. Kantor, L.S. Zijenah, R.W. Shafer <em>et al.</em></li><li class="title"><p>HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy</p></li><li class="source"><p>AIDS Res. Hum. Retroviruses, 18 (2002), pp. 1407–1413</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref48" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref48'] = new Array();
        </script></li><li id="BIB49" data-t="r"><ul class="reference" id="bibsbref49"><li class="referenceLabel"><a href="#BIB49" class="label intra_ref">Kantor and Katzenstein, 2003</a></li><li class="author">R. Kantor, D Katzenstein</li><li class="title"><p>Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution</p></li><li class="source"><p>AIDS Rev, 5 (2003), pp. 25–35</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref49" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref49'] = new Array();
        </script></li><li id="BIB50" data-t="r"><ul class="reference" id="bibsbref50"><li class="referenceLabel"><a href="#BIB50" class="label intra_ref">Kaplan et al., 1994</a></li><li class="author">A.H. Kaplan, S.F. Michael, R.S. Wehbie <em>et al.</em></li><li class="title"><p>Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease</p></li><li class="source"><p>Proc. Natl. Acad. Sci. USA, 91 (1994), pp. 5597–5601</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref50" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref50'] = new Array();
        </script></li><li id="BIB51" data-t="r"><ul class="reference" id="bibsbref51"><li class="referenceLabel"><a href="#BIB51" class="label intra_ref">Korber et al., 2000</a></li><li class="author">B. Korber, M. Muldoon, J. Theiler <em>et al.</em></li><li class="title"><p>Timing the ancestor of the HIV-1 pandemic strains</p></li><li class="source"><p>Science, 288 (2000), pp. 1789–1796</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref51" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref51'] = new Array();
        </script></li><li id="BIB52" data-t="r"><ul class="reference" id="bibsbref52"><li class="referenceLabel"><a href="#BIB52" class="label intra_ref">Kuiken et al., 2000</a></li><li class="author">C. Kuiken, B. Foley, B. Hahn <em>et al.</em></li><li class="source"><p>HIV Sequence Compendium 2000Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM (2000)</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref52" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref52'] = new Array();
        </script></li><li id="BIB53" data-t="r"><ul class="reference" id="bibsbref53"><li class="referenceLabel"><a href="#BIB53" class="label intra_ref">Little et al., 1999</a></li><li class="author">S.J. Little, E.S. Daar, R.T. D'Aquila <em>et al.</em></li><li class="title"><p>Reduced antiretroviral drug susceptibility among patients with primary HIV infection</p></li><li class="source"><p>J. Am. Med. Assoc., 282 (1999), pp. 1142–1149</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref53" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref53'] = new Array();
        </script></li><li id="BIB54" data-t="r"><ul class="reference" id="bibsbref54"><li class="referenceLabel"><a href="#BIB54" class="label intra_ref">Little et al., 2002</a></li><li class="author">S.J. Little, S. Holte, J.P. Routy <em>et al.</em></li><li class="title"><p>Antiretroviral-drug resistance among patients recently infected with HIV</p></li><li class="source"><p>New Engl. J. Med., 347 (2002), pp. 385–394</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref54" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref54'] = new Array();
        </script></li><li id="BIB55" data-t="r"><ul class="reference" id="bibsbref55"><li class="referenceLabel"><a href="#BIB55" class="label intra_ref">Loveday, 2001</a></li><li class="author">C. Loveday</li><li class="title"><p>International perspectives on antiretroviral resistance. Nucleoside reverse transcriptase inhibitor resistance</p></li><li class="source"><p>J. Acquir. Immune Defic. Syndr., 26 (suppl. 1) (2001), pp. S10–S24</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref55" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref55'] = new Array();
        </script></li><li id="BIB56" data-t="r"><ul class="reference" id="bibsbref56"><li class="referenceLabel"><a href="#BIB56" class="label intra_ref">Maguire et al., 2002</a></li><li class="author">M. Maguire, D. Shortino, A. Klein <em>et al.</em></li><li class="title"><p>Emergence of resistance to protease inhibitor amprenavir in human immunodeficiency virus type 1-infected patients: selection of four alternative viral protease genotypes and influence of viral susceptibility to coadministered reverse transcriptase nucleoside inhibitors</p></li><li class="source"><p>Antimicrob. Agents Chemother., 46 (2002), pp. 731–738</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref56" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref56'] = new Array();
        </script></li><li id="BIB57" data-t="r"><ul class="reference" id="bibsbref57"><li class="referenceLabel"><a href="#BIB57" class="label intra_ref">McCutchan, 2000</a></li><li class="author">F.E. McCutchan</li><li class="title"><p>Understanding the genetic diversity of HIV-1</p></li><li class="source"><p>AIDS, 14 (2000), pp. S31–S44</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref57" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref57'] = new Array();
        </script></li><li id="BIB58" data-t="r"><ul class="reference" id="bibsbref58"><li class="referenceLabel"><a href="#BIB58" class="label intra_ref">Meynard et al., 2002</a></li><li class="author">J.L. Meynard, M. Vray, L. Morand-Joubert <em>et al.</em></li><li class="title"><p>Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial</p></li><li class="source"><p>AIDS, 16 (2002), pp. 727–736</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref58" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref58'] = new Array();
        </script></li><li id="BIB59" data-t="r"><ul class="reference" id="bibsbref59"><li class="referenceLabel"><a href="#BIB59" class="label intra_ref">Miller, 2001</a></li><li class="author">V. Miller</li><li class="title"><p>Resistance to protease inhibitors</p></li><li class="source"><p>J. Acquir. Immune Defic. Syndr., 26 (suppl. 1) (2001), pp. S34–S50</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref59" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref59'] = new Array();
        </script></li><li id="BIB60" data-t="r"><ul class="reference" id="bibsbref60"><li class="referenceLabel"><a href="#BIB60" class="label intra_ref">Nkengasong et al., 1998</a></li><li class="author">J. Nkengasong, F. Sylla-Koko, M. Peeters <em>et al.</em></li><li class="title"><p>HIV-1 group O virus infection in Abidjan, Cote d'Ivoire</p></li><li class="source"><p>AIDS, 12 (1998), pp. 1565–1566</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref60" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref60'] = new Array();
        </script></li><li id="BIB61" data-t="r"><ul class="reference" id="bibsbref61"><li class="referenceLabel"><a href="#BIB61" class="label intra_ref">Osmanov et al., 2002</a></li><li class="author">S. Osmanov, C. Pattou, N. Walker, B. Schwardlander, J. Esparza</li><li class="title"><p>Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000</p></li><li class="source"><p>J. Acquir. Immune Defic. Syndr., 29 (2002), pp. 184–190</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref61" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref61'] = new Array();
        </script></li><li id="BIB62" data-t="r"><ul class="reference" id="bibsbref62"><li class="referenceLabel"><a href="#BIB62" class="label intra_ref">Peeters, 2001</a></li><li class="author">M. Peeters</li><li class="title"><p>The genetic variability of HIV-1 and its implications</p></li><li class="source"><p>Transfus. Clin. Biol., 8 (2001), pp. 222–225</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref62" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref62'] = new Array();
        </script></li><li id="BIB63" data-t="r"><ul class="reference" id="bibsbref63"><li class="referenceLabel"><a href="#BIB63" class="label intra_ref">Peeters and Sharp, 2000</a></li><li class="author">M. Peeters, P.M. Sharp</li><li class="title"><p>Genetic diversity of HIV-1: the moving target</p></li><li class="source"><p>AIDS, 14 (2000), pp. S129–S140</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref63" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref63'] = new Array();
        </script></li><li id="BIB64" data-t="r"><ul class="reference" id="bibsbref64"><li class="referenceLabel"><a href="#BIB64" class="label intra_ref">Perez-Alvarez et al., 2001a</a></li><li class="author">L. Perez-Alvarez, M.T. Cuevas, M.L. Villahermosa <em>et al.</em></li><li class="title"><p>Prevalence of drug resistance mutations in B, non-B subtypes, and recombinant forms of human immunodeficiency virus type 1 in infected individuals in Spain (Galicia)</p></li><li class="source"><p>J. Hum. Virol., 4 (2001), pp. 35–38</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref64" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref64'] = new Array();
        </script></li><li id="BIB65" data-t="r"><ul class="reference" id="bibsbref65"><li class="referenceLabel"><a href="#BIB65" class="label intra_ref">Perez-Alvarez et al., 2001b</a></li><li class="author">L. Perez-Alvarez, M.M. Thomson, M.L. Villahermosa <em>et al.</em></li><li class="title"><p>HIV-1 subtype G and BG recombinant viruses in Spanish natives: evidence of characteristic mutations in reverse transcriptase and protease</p></li><li class="source"><p>AIDS, 15 (2001), pp. 1907–1910</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref65" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref65'] = new Array();
        </script></li><li id="BIB66" data-t="r"><ul class="reference" id="bibsbref66"><li class="referenceLabel"><a href="#BIB66" class="label intra_ref">Pillay et al., 2002</a></li><li class="author">D. Pillay, A.S. Walker, D.M. Gibb <em>et al.</em></li><li class="title"><p>Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the paediatric European network for treatment of AIDS (PENTA) 5 Trial</p></li><li class="source"><p>J. Infect. Dis., 186 (2002), pp. 617–625</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref66" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref66'] = new Array();
        </script></li><li id="BIB67" data-t="r"><ul class="reference" id="bibsbref67"><li class="referenceLabel"><a href="#BIB67" class="label intra_ref">Reeves and Doms, 2002</a></li><li class="author">J.D. Reeves, R.W. Doms</li><li class="title"><p>Human immunodeficiency virus type 2</p></li><li class="source"><p>J. Gen. Virol., 83 (2002), pp. 1253–1265</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref67" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref67'] = new Array();
        </script></li><li id="BIB68" data-t="r"><ul class="reference" id="bibsbref68"><li class="referenceLabel"><a href="#BIB68" class="label intra_ref">Ren et al., 2002</a></li><li class="author">J. Ren, L.E. Bird, P.P. Chamberlain, G.B. Stewart-Jones, D.I. Stuart, D.K. Stammers</li><li class="title"><p>Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors</p></li><li class="source"><p>Proc. Natl. Acad. Sci. USA, 99 (2002), pp. 14410–14415</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref68" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref68'] = new Array();
        </script></li><li id="BIB69" data-t="r"><ul class="reference" id="bibsbref69"><li class="referenceLabel"><a href="#BIB69" class="label intra_ref">Richman et al., 2001</a></li><li class="source">Richman D, Bozzette S, Morton S, et al. The prevalence of antiretroviral drug resistance in the US, 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, IL, 2001. p. Abstract LB-17.</li><li data-sr="N" class="external refPlaceHolder" id="bibsbref69" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref69'] = new Array();
        </script></li><li id="BIB70" data-t="r"><ul class="reference" id="bibsbref70"><li class="referenceLabel"><a href="#BIB70" class="label intra_ref">Robertson et al., 1995a</a></li><li class="author">D.L. Robertson, B.H. Hahn, P.M. Sharp</li><li class="title"><p>Recombination in AIDS viruses</p></li><li class="source"><p>J. Mol. Evol., 40 (1995), pp. 249–259</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref70" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref70'] = new Array();
        </script></li><li id="BIB71" data-t="r"><ul class="reference" id="bibsbref71"><li class="referenceLabel"><a href="#BIB71" class="label intra_ref">Robertson et al., 1995b</a></li><li class="author">D.L. Robertson, P.M. Sharp, F.E. McCutchan, B.H. Hahn</li><li class="title"><p>Recombination in HIV-1 [letter]</p></li><li class="source"><p>Nature, 374 (1995), pp. 124–126</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref71" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref71'] = new Array();
        </script></li><li id="BIB72" data-t="r"><ul class="reference" id="bibsbref72"><li class="referenceLabel"><a href="#BIB72" class="label intra_ref">Robertson et al., 2000a</a></li><li class="author">D.L. Robertson, J.L. Anderson, J.A. Bradac <em>et al.</em></li><li class="title"><p>HIV-1 nomenclature proposal a reference guide to HIV-1 classification</p></li><li class="source"><p>C.L. Kuiken, B. Foley, B.H. Hahn (Eds.) <em>et al.</em>, Human Retroviruses and AIDS: a Compilation and Analysis of Nucleic and Amino Acid Sequences, Los Alamos National Laboratory, Los Alamos, NM (2000), pp. 492–505</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref72" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref72'] = new Array();
        </script></li><li id="BIB73" data-t="r"><ul class="reference" id="bibsbref73"><li class="referenceLabel"><a href="#BIB73" class="label intra_ref">Robertson et al., 2000b</a></li><li class="author">D.L. Robertson, J.P. Anderson, J.A. Bradac <em>et al.</em></li><li class="title"><p>HIV-1 nomenclature proposal [letter]</p></li><li class="source"><p>Science, 288 (2000), pp. 55–56</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref73" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref73'] = new Array();
        </script></li><li id="BIB74" data-t="r"><ul class="reference" id="bibsbref74"><li class="referenceLabel"><a href="#BIB74" class="label intra_ref">Rubio et al., 1997</a></li><li class="author">A. Rubio, M. Leal, J.A. Pineda <em>et al.</em></li><li class="title"><p>Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1-infected antiviral-naive patients from 1989 to 1996</p></li><li class="source"><p>AIDS, 11 (1997), pp. 1184–1186</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref74" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref74'] = new Array();
        </script></li><li id="BIB75" data-t="r"><ul class="reference" id="bibsbref75"><li class="referenceLabel"><a href="#BIB75" class="label intra_ref">Ruibal-Brunet et al., 2001</a></li><li class="author">I.J. Ruibal-Brunet, M.T. Cuevas, H. Diaz-Torres <em>et al.</em></li><li class="title"><p>Genotypic resistance mutations to antiretroviral drugs in HIV-1 B and non-B subtypes from Cuba</p></li><li class="source"><p>Rev. Panam. Salud. Publica., 10 (2001), pp. 174–180</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref75" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref75'] = new Array();
        </script></li><li id="BIB76" data-t="r"><ul class="reference" id="bibsbref76"><li class="referenceLabel"><a href="#BIB76" class="label intra_ref">Salminen et al., 1995</a></li><li class="author">M.O. Salminen, J.K. Carr, D.S. Burke, F.E. McCutchan</li><li class="title"><p>Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning</p></li><li class="source"><p>AIDS Res. Hum. Retroviruses, 11 (1995), pp. 1423–1425</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref76" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref76'] = new Array();
        </script></li><li id="BIB77" data-t="r"><ul class="reference" id="bibsbref77"><li class="referenceLabel"><a href="#BIB77" class="label intra_ref">Shafer, 2002</a></li><li class="author">R.W. Shafer</li><li class="title"><p>Genotypic testing for human immunodeficiency virus type 1 drug resistance</p></li><li class="source"><p>Clin. Microbiol. Rev., 15 (2002), pp. 247–277</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref77" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref77'] = new Array();
        </script></li><li id="BIB78" data-t="r"><ul class="reference" id="bibsbref78"><li class="referenceLabel"><a href="#BIB78" class="label intra_ref">Shafer et al., 2000</a></li><li class="author">R.W. Shafer, R. Kantor, M.J. Gonzales</li><li class="title"><p>The genetic basis of HIV-1 resistance to reverse transcriptase and protease inhibitors</p></li><li class="source"><p>AIDS Rev., 2 (2000), pp. 211–218</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref78" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref78'] = new Array();
        </script></li><li id="BIB79" data-t="r"><ul class="reference" id="bibsbref79"><li class="referenceLabel"><a href="#BIB79" class="label intra_ref">Simon et al., 1998</a></li><li class="author">F. Simon, P. Mauclere, P. Roques <em>et al.</em></li><li class="title"><p>Identification of a new human immunodeficiency virus type 1 distinct from group M and group O</p></li><li class="source"><p>Nat. Med., 4 (1998), pp. 1032–1037</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref79" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref79'] = new Array();
        </script></li><li id="BIB80" data-t="r"><ul class="reference" id="bibsbref80"><li class="referenceLabel"><a href="#BIB80" class="label intra_ref">Soriano and de Mendoza, 2002a</a></li><li class="author">V. Soriano, C. de Mendoza</li><li class="title"><p>Genetic mechanisms of resistance to NRTI and NNRTI</p></li><li class="source"><p>HIV Clin. Trials, 3 (2002), pp. 237–248</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref80" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref80'] = new Array();
        </script></li><li id="BIB81" data-t="r"><ul class="reference" id="bibsbref81"><li class="referenceLabel"><a href="#BIB81" class="label intra_ref">Soriano and de Mendoza, 2002b</a></li><li class="author">V. Soriano, C. de Mendoza</li><li class="title"><p>Genetic mechanisms of resistance to protease inhibitors and entry inhibitors</p></li><li class="source"><p>HIV Clin. Trials, 3 (2002), pp. 249–257</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref81" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref81'] = new Array();
        </script></li><li id="BIB82" data-t="r"><ul class="reference" id="bibsbref82"><li class="referenceLabel"><a href="#BIB82" class="label intra_ref">Thomson and Najera, 2001</a></li><li class="author">M.M. Thomson, R. Najera</li><li class="title"><p>Travel and the introduction of human immunodeficiency virus type 1 non- B subtype genetic forms into Western countries</p></li><li class="source"><p>Clin. Infect. Dis., 32 (2001), pp. 1732–1737</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref82" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref82'] = new Array();
        </script></li><li id="BIB83" data-t="r"><ul class="reference" id="bibsbref83"><li class="referenceLabel"><a href="#BIB83" class="label intra_ref">Triques et al., 2000</a></li><li class="author">K. Triques, A. Bourgeois, N. Vidal <em>et al.</em></li><li class="title"><p>Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K</p></li><li class="source"><p>AIDS Res. Hum. Retroviruses, 16 (2000), pp. 139–151</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref83" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref83'] = new Array();
        </script></li><li id="BIB84" data-t="r"><ul class="reference" id="bibsbref84"><li class="referenceLabel"><a href="#BIB84" class="label intra_ref">Tural et al., 2002</a></li><li class="author">C. Tural, L. Ruiz, C. Holtzer <em>et al.</em></li><li class="title"><p>Clinical utility of HIV-1 genotyping and expert advice: the Havana trial</p></li><li class="source"><p>AIDS, 16 (2002), pp. 209–218</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref84" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref84'] = new Array();
        </script></li><li id="BIB85" data-t="r"><ul class="reference" id="bibsbref85"><li class="referenceLabel"><a href="#BIB85" class="label intra_ref">Vanden et al., 1996</a></li><li class="author">H.M. Vanden, M. Peeters, G. Jannes <em>et al.</em></li><li class="title"><p>Sequence analysis of a highly divergent HIV-1-related lentivirus isolated from a wild captured chimpanzee</p></li><li class="source"><p>Virology, 221 (1996), pp. 346–350</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref85" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref85'] = new Array();
        </script></li><li id="BIB86" data-t="r"><ul class="reference" id="bibsbref86"><li class="referenceLabel"><a href="#BIB86" class="label intra_ref">Vergne et al., 2002</a></li><li class="author">L. Vergne, G. Malonga-Mouellet, I. Mistoul <em>et al.</em></li><li class="title"><p>Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries</p></li><li class="source"><p>J. Acquir. Immune Defic. Syndr., 29 (2002), pp. 165–168</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref86" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref86'] = new Array();
        </script></li><li id="BIB87" data-t="r"><ul class="reference" id="bibsbref87"><li class="referenceLabel"><a href="#BIB87" class="label intra_ref">Weidle et al., 2002</a></li><li class="author">P.J. Weidle, S. Malamba, R. Mwebaze <em>et al.</em></li><li class="title"><p>Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients’ response, survival, and drug resistance</p></li><li class="source"><p>Lancet, 360 (2002), pp. 34–40</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref87" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref87'] = new Array();
        </script></li><li id="BIB88" data-t="r"><ul class="reference" id="bibsbref88"><li class="referenceLabel"><a href="#BIB88" class="label intra_ref">Yang et al., 1996</a></li><li class="author">G. Yang, Q. Song, M. Charles, W.C. Drosopoulos, E. Arnold, V.R. Prasad</li><li class="title"><p>Use of chimeric human immunodeficiency virus types 1 and 2 reverse transcriptases for structure–function analysis and for mapping susceptibility to nonnucleoside inhibitors</p></li><li class="source"><p>J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 11 (1996), pp. 326–333</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref88" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref88'] = new Array();
        </script></li><li id="BIB89" data-t="r"><ul class="reference" id="bibsbref89"><li class="referenceLabel"><a href="#BIB89" class="label intra_ref">Yerly et al., 1998</a></li><li class="author">S. Yerly, A. Rakik, S.K. De Loes <em>et al.</em></li><li class="title"><p>Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants</p></li><li class="source"><p>J. Virol., 72 (1998), pp. 3520–3523</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref89" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref89'] = new Array();
        </script></li><li id="BIB90" data-t="r"><ul class="reference" id="bibsbref90"><li class="referenceLabel"><a href="#BIB90" class="label intra_ref">Yerly et al., 1999</a></li><li class="author">S. Yerly, L. Kaiser, E. Race, J.P. Bru, F. Clavel, L. Perrin</li><li class="title"><p>Transmission of antiretroviral-drug-resistant HIV-1 variants</p></li><li class="source"><p>Lancet, 354 (1999), pp. 729–733</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref90" data-refres="N"><img class="refimgLoader" alt="" src="loading_icon.gif"></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref90'] = new Array();
        </script></li></ol><div class="artFooterContent"><dl class="correspondence" id="COR1"><dt class="label topPadd"><a href="#bCOR1" class="intra_ref"><sup><img style="display: inline;" class="imgLazyJSB" src="grey_pxl.gif" alt="Corresponding author contact information" title="Corresponding author contact information" data-inlimg="/entities/REcor.gif" border="0"><noscript><img border="0" alt="Corresponding author contact information" title="Corresponding author conact information" src="http://origin-cdn.els-cdn.com/sd/entities/REcor.gif"></noscript></sup></a></dt><dd>Corresponding author. Tel.: +1-650-736-0436; fax: +1-208-975-1490.</dd></dl><!--footerNotes--></div><!--VALIDHTML--><p class="copyright">Copyright © 2003 Elsevier B.V. All rights reserved.</p><!--VALIDHTML-->
<script>prs.rt('data_end');</script>
       
        
    <div style="height: 0px;" id="pStretcher"></div></div>
 </div>
 <div style="top: 26px; overflow: hidden; left: 961px; width: 640px;" id="rightPane" class="column js" aria-label="Related content" role="complementary">
   <div style="display: none;" class="toggleSideBar">
      <a tabindex="0">
         <div class="close" title="Open to view article outline"></div>
      </a>
    </div>
    <iframe class="dummyiFrame" border="0" style="position: absolute; background: none repeat ; 0% transparent; border: 0px none; top: 0px; left: 0px; width: 100%; height: 100%; z-index: -1;" src="S138665320300115X_1.html" frameborder="0"></iframe>
    <div style="margin-left: 0px; width: 638px;" role="tablist" id="rightInner" class="rightInner js ui-accordion ui-widget ui-helper-reset">
       <h2 tabindex="-1" aria-selected="false" aria-controls="ui-accordion-rightInner-panel-0" id="ui-accordion-rightInner-header-0" role="tab" class="accordionHead first-tab bibliographic ui-accordion-header ui-helper-reset ui-state-default ui-corner-all">
    <span class="showHideIcon"></span>
    Bibliographic information
</h2>
<div aria-hidden="true" aria-expanded="false" role="tabpanel" aria-labelledby="ui-accordion-rightInner-header-0" id="ui-accordion-rightInner-panel-0" style="display: none; height: 391px; overflow: auto; background-color: rgb(236, 242, 246);" class="accordionContent ui-accordion-content ui-helper-reset ui-widget-content ui-corner-bottom">
    <div style="width: 605px;" class="innerPadding js_bibliographic_content">

    </div>
</div>


  <h2 tabindex="0" aria-selected="true" aria-controls="ui-accordion-rightInner-panel-1" id="ui-accordion-rightInner-header-1" role="tab" class="accordionHead relatedArticles ui-accordion-header ui-helper-reset ui-state-default ui-accordion-header-active ui-state-active ui-corner-top">
    <span class="showHideIcon"></span>
    Citing and related articles
  </h2>
  <div aria-hidden="false" aria-expanded="true" role="tabpanel" aria-labelledby="ui-accordion-rightInner-header-1" id="ui-accordion-rightInner-panel-1" style="display: block; height: 391px; background-color: rgb(236, 242, 246); overflow: auto;" class="accordionContent ui-accordion-content ui-helper-reset ui-widget-content ui-corner-bottom ui-accordion-content-active">
    <div style="width: 605px;" class="innerPadding js_citation_content">
      
        
     

     
     
        <div class="articleList">
             <h3>Related articles</h3>
             <ol id="relArtList"><li class="note"><p>No articles found.</p></li></ol>
        </div>
     

     
         
             <ol class="citedByLink"><div class="boxLink"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=outwardLink&amp;_partnerName=656&amp;_eid=1-s2.0-S138665320300115X&amp;_pii=S138665320300115X&amp;_origin=article&amp;_zone=art_page&amp;_targetURL=http%3A%2F%2Fwww.scopus.com%2Finward%2Fcitedby.url%3Feid%3D2-s2.0-1042287077%26partnerID%3D10%26rel%3DR3.0.0%26md5%3Dddb39c5b783104c61eea472474c03e14&amp;_acct=C000007922&amp;_version=1&amp;_userid=103680&amp;md5=fb22aeb67eac8b5e1bc826b854d2f346" rel="nofollow" class="olSpawnWindow" target="outwardLink"><span class="scopus_logo_txt">Cited by in Scopus (64)</span></a></div></ol>
         
     

     
         
             <div class="articleList">
                 <h3>Related reference work articles</h3>
                 <ol id="relRefList"><li class="note"><p>No articles found.</p></li></ol>
             </div>
         
      

    </div>
  </div>



  <h2 tabindex="-1" aria-selected="false" aria-controls="ui-accordion-rightInner-panel-2" id="ui-accordion-rightInner-header-2" role="tab" class="accordionHead applications ui-accordion-header ui-helper-reset ui-state-default ui-corner-all">
    <span class="showHideIcon"></span>
    Applications and tools
  </h2>
  <div aria-hidden="true" aria-expanded="false" role="tabpanel" aria-labelledby="ui-accordion-rightInner-header-2" id="ui-accordion-rightInner-panel-2" style="height: 391px; overflow: auto; visibility: hidden; top: -1000px; position: absolute; left: -1000px;" class="accordionContent ui-helper-reset ui-widget-content ui-corner-bottom">
    <div style="width: 625px;" class="innerPaddingApp js_application_content">

      
        <div id="SD_AT1P" class="boxLink sgfNoTitleBar sgfNoGadgetBorder"></div>
      

      
        <div id="SD_FTA1" class="boxLink sgfHorToolbar sgfShowMyApps sgfShowMoreLessApps"></div>
      

    </div>
  </div>


<h2 tabindex="-1" aria-selected="false" aria-controls="ui-accordion-rightInner-panel-3" id="ui-accordion-rightInner-header-3" role="tab" class="accordionHead last-tab workspace ui-accordion-header ui-helper-reset ui-state-default ui-corner-all">
    <span class="showHideIcon"></span>
    Workspace
</h2>
<div aria-hidden="true" aria-expanded="false" role="tabpanel" aria-labelledby="ui-accordion-rightInner-header-3" id="ui-accordion-rightInner-panel-3" style="display: none; height: 391px; overflow: auto;" class="accordionContent ui-accordion-content ui-helper-reset ui-widget-content ui-corner-bottom">
    <div style="" class="innerPadding js_workspace_content">
        <div style="width: 600px;" class="scrollArea">
           <li class="note"><p>No content has been selected.</p></li>
           <div id="workSpaceView"></div>
        </div>
    </div>
    <div class="hidescrollbar"></div>
</div>

    </div>
 </div>
</div>
<div style="clear: both;"></div>
<div style="width: 1606px; left: 155px; height: 0px; display: none;" class="js" id="footer-area" aria-label="product support" role="contentinfo">
  <div id="sdFoot">
    <div id="footer">	
  <div class="bottomArticle"></div>
  <div class="padding">
    <div id="linkArea">
      <div class="padding">
        <div style="float: left; width: 0px; height: 1px;"></div>
        <div id="banner-bottom">
          <a href="http://www.elsevier.com.libgate.library.nuigalway.ie/" target="_top"><img src="wordmark_elsevier.png" alt="Elsevier homepage (opens in a new window)" title="Elsevier homepage (opens in a new window)"></a>
        </div>
        <ul class="col5">
<li><a target="_top" href="http://www.info.sciverse.com/sciencedirect?utm_source=sciencedirect&amp;utm_medium=link&amp;utm_campaign=aboutsd">About ScienceDirect</a></li>
</ul>
<ul class="col5">
<li><a target="_top" href="http://www.elsevier.com.libgate.library.nuigalway.ie/?utm_source=sciencedirect&amp;utm_medium=link&amp;utm_campaign=aboutelsevier">About Elsevier</a></li>
</ul>
<ul class="col5">
<li> <a target="_top" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/contactus">Contact and support</a></li>
</ul>
<ul class="col5">
<li><a target="_top" href="http://www.elsevierscitech.com/forms/sd/form.html?utm_source=sciencedirect&amp;utm_medium=link&amp;utm_campaign=advert">Information for advertisers</a></li>
</ul>
<ul class="col5">
<li><a target="_top" href="http://www.elsevier.com.libgate.library.nuigalway.ie/locate/termsandconditions?utm_source=sciencedirect&amp;utm_medium=link&amp;utm_campaign=terms">Terms and conditions</a></li>
</ul>
<ul class="col5">
<li><a target="_top" href="http://www.elsevier.com.libgate.library.nuigalway.ie/privacypolicy?utm_source=sciencedirect&amp;utm_medium=link&amp;utm_campaign=privacy">Privacy policy</a></li>
</ul>
<script>function loadSCode(){if(typeof SDM!="undefined"){var e=document.getElementsByTagName("body")[0],t=document.createElement("script");t.src="//cdn.els-cdn.com/sd/js/adobe/s_code_131.js";e.appendChild(t);sendSCStats()}else{setTimeout(loadSCode,100)}}function sendSCStats(){if(typeof s_tc_sciencedirect!="undefined"){s.t()}else{setTimeout(sendSCStats,100)}}if(window.addEventListener){window.addEventListener("load",loadSCode,false)}else if(window.attachEvent){window.attachEvent("onload",loadSCode)}else{window.onload=loadSCode}</script>
        <div class="clear"></div>
        <!-- CSAS will be providing the links-->
      </div>
      <div class="padding" style="padding-top: 8px; padding-bottom: 4px; font-size: 11px;">

        Copyright © 2013 <a href="http://www.elsevier.com.libgate.library.nuigalway.ie/" target="_top">Elsevier B.V.</a> All rights reserved.  SciVerse® is a registered trademark of Elsevier Properties S.A., used under license. ScienceDirect® is a registered trademark of Elsevier B.V.
      </div>
      <div class="padding" style="padding-bottom: 4px; padding-top: 0px; font-size: 11px;">

              Cookies are used by this site. To decline or learn more, visit our <a href="http://www.info.sciverse.com/sciencedirect/cookies" target="_top">Cookies</a> page
        </div> 
    </div>
  </div>
</div> <!--footer-->

  </div><!--sdFooter-->
</div><!--footer-area-->


<form name="citationInfo" id="citationInfo" method="POST" action="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/article/pii/S138665320300115X?np=y">
    <input name="art_citation" value="" type="hidden">
</form>
<div id="pdfModalWindow" class="pdfModalWindow" style="display: none;" onclick="pdfCite.closePopup();"></div>


<!-- PDFKING/PDFCITE -->
<div id="suggestedPdfList" style="display: none;">

</div>


<script src="sdX_131R4.js"></script>
<script src="sd_131R4.js"></script>
<script>

var sciverse="empty";
var SDM=new Object;
SDM.tm=new Object;
SDM.tm.ahm='h'
SDM.tm.chm='h'


SDM.pm=new Object;
SDM.pm.contentType = 'JL';
SDM.doi = '10.1016/S1386-6532(03)00115-X';
SDM.pm.issn_or_isbn = "13866532";
SDM.pm.mod_ISBN = "";
  SDM.isMRWMODArticle = false ; 
 
SDM.pm.mod_cid="";
SDM.pm.mod_srcTitle="";
SDM.pm.pii = 'S138665320300115X';
SDM.pm.cid = '271981';
SDM.pm.eid = '1-s2.0-S138665320300115X';
SDM.pm.pdfEid = '1-s2.0-S138665320300115X-main.pdf';
SDM.pm.pdfSize = '226950';
SDM.pm.coverDate = '2004-Mar-31';
SDM.pm.itemWeight = 'FULL-TEXT';
SDM.pm.indexType = '';





SDM.pf = new Object;
SDM.pf.dc = new Object;
SDM.pf.dc.retry = 10;
SDM.pf.dc.retryDelay = 300;
SDM.pf.dc.retryFactor = 1.0;

SDM.pf.er = new Object;

SDM.pf.er.epub = new Object;
SDM.pf.er.epub.name = 'ePub';
SDM.pf.er.epub.retry = 5;
SDM.pf.er.epub.retryDelay = 2000;
SDM.pf.er.epub.retryFactor = 1.0;
SDM.pf.er.epub.msgDelay = 1500;
SDM.pf.er.epub.msgType = 'rect';
SDM.pf.er.epub.msgImg = 'epubAnim.gif';
SDM.pf.er.epub.url='http://www.sciencedirect.com/science/ereader/epub/S138665320300115X/1368789110/13866532/1-s2.0-S138665320300115X/serial/?md5=114b667ad18a33bff7a15c0a9412e384';


SDM.pf.er.mobi = new Object;
SDM.pf.er.mobi.name = 'Mobipocket';
SDM.pf.er.mobi.retry = 5;
SDM.pf.er.mobi.retryDelay = 2000;
SDM.pf.er.mobi.retryFactor = 1.0;
SDM.pf.er.mobi.msgDelay = 1500;
SDM.pf.er.mobi.msgType = 'rect';
SDM.pf.er.mobi.msgImg = 'mobiAnim.gif';
SDM.pf.er.mobi.url='http://www.sciencedirect.com/science/ereader/mobi/S138665320300115X/1368789110/13866532/1-s2.0-S138665320300115X/serial/?md5=114b667ad18a33bff7a15c0a9412e384';






SDM.pm.toc=new Object;
SDM.pm.toc.retry = 20;
SDM.pm.toc.retryDelay = 1000;
SDM.pm.toc.retryFactor = 1.09;
 SDM.tocJson = '{"PII":"S138665320300115X","EID":"1-s2.0-S138665320300115X","TIMESTAMP":"2010-12-22T17:01:33.515753-05:00","TOC":[{"dummy": "dummy"}, {"sT":"Abstract", "sID":"section_abstract", "cT":[ {"sT":"", "sID":"absSec_1" } ] }, {"sT":"Keywords", "sID":"kwd_1"}, {"sT":"Abbreviations", "sID":"kwd_2"}, {"sT":"1. HIV-1 diversity", "sID":"section_lbl1", "faID":[ {"dummy": "dummy"}, {"fID":"FIG1", "fT":"fig","fL":"Fig. 1", "fI":"gr1.sml","fIh":"93"}, {"fID":"FIG2", "fT":"fig","fL":"Fig. 2", "fI":"gr2.sml","fIh":"82"} ] },{"sT":"2. HIV-1 drug resistance", "sID":"section_lbl2", "faID":[ {"dummy": "dummy"} ] },{"sT":"3. HIV-1 drug resistance in untreated individuals", "sID":"section_lbl3", "faID":[ {"dummy": "dummy"} ] },{"sT":"4. HIV-1 drug resistance in treated individuals", "sID":"section_lbl4", "faID":[ {"dummy": "dummy"}, {"fID":"FIG3", "fT":"fig","fL":"Fig. 3", "fI":"gr3.sml","fIh":"93"},{"fID":"TBL1", "fT":"tbl","fL":"Table 1"} ] },{"sT":"5. Studies in Africa", "sID":"section_lbl5", "faID":[ {"dummy": "dummy"} ] },{"sT":"6. Studies in Europe", "sID":"section_lbl6", "faID":[ {"dummy": "dummy"} ] },{"sT":"7. Studies in South America and Cuba", "sID":"section_lbl7", "faID":[ {"dummy": "dummy"} ] },{"sT":"8. Studies in Israel", "sID":"section_lbl8", "faID":[ {"dummy": "dummy"} ] },{"sT":"9. Summary and conclusions", "sID":"section_lbl9", "faID":[ {"dummy": "dummy"} ] , "cT":[ {"sT":"9.1. NRTIs", "sID":"section_lbl9.1", "faID":[ {"dummy": "dummy"} ] },{"sT":"9.2. NNRTIs", "sID":"section_lbl9.2", "faID":[ {"dummy": "dummy"} ] },{"sT":"9.3. PIs", "sID":"section_lbl9.3", "faID":[ {"dummy": "dummy"} ] } ]}, {"sT":"References", "sID":"bibl001"} ]}';
 SDM.tocCacheAvail=true; 


SDM.ep=new Object;
SDM.ep.imgBase = "http://cdn.els-cdn.com/sd";
SDM.ep.urlPrefix = "http://www.sciencedirect.com/science";
SDM.ep.refLinkURL = "http://www.sciencedirect.com/science/relLink/ajaxReq?_eid=1-s2.0-S138665320300115X";
SDM.ep.updatedCitedBy = "http://www.sciencedirect.com/science/referenceResolution/ajaxRefResol?_updateCitedBy=";
SDM.ep.refResolvePath = "http://www.sciencedirect.com/science/referenceResolution/ajaxRefResol?_eid=1-s2.0-S138665320300115X&_refCnt=90&_docType=converted-article";
SDM.breadCrumbPathURL = "http://www.sciencedirect.com/science/module/breadCrumbPaths/isbn//pii/S138665320300115X";

SDM.ldrAvail = true;
SDM.ep.crossMarkURL = "http://www.sciencedirect.com/science/crossMark";
SDM.ep.crossMarkLib = "http://crossmark.crossref.org/javascripts/crossmark.min.js";
SDM.ep.userActionURL = "http://www.sciencedirect.com/science/UserActions"
SDM.ep.svShindigLib="http://sciverse-shindig.elsevier.com/gadgets/js/shindig-container:pubsub-2.js?c=1";
SDM.ep.svSciverseLib="http://www.sciencedirect.com/gadgetservices/gadgets/v3_1/js/SciverseShindigService,GadgetToolBar,jquery-outside,jquery.ba-bbq.min,SciverseShindigContainer,ScienceDirectShindigServices.js";
SDM.ep.downloadCsvURL = "http://services.elsevier.com/SDWebExport/export/table/csv";
SDM.ep.downloadActionURL = "http://www.sciencedirect.com/science/downloadActions/keyEvent/S138665320300115X/13866532";
SDM.ep.gigyaLib="//cdn.gigya.com/JS/socialize.js?apiKey=3__Bt7bHrGM8mjKPwBuOVjWyMi678aF6-PewcnoHJJ6UR1fS5t9NG9RBbKHjE0oA6J";

SDM.urlPrefix = "http://www.sciencedirect.com/science";
SDM.refLinkURL = "http://www.sciencedirect.com/science/relLink/ajaxReq?_eid=1-s2.0-S138665320300115X";

SDM.imageUrlPrefix = "http://ars.els-cdn.com/content/image/";
SDM.staticImageUrlPrefix = "http://cdn.els-cdn.com/sd";

SDM.prodColor="sci_dir";if(SDM.prodColor=="sci_dir")SDM.prodColor="";

SDM.pageTransKey = "05/17/2013 07:11:50 EDT#1849_002#18385#140.203.12.206";
SDM.pageType = "article_full";

  SDM.webUserId = "103680";
  SDM.contentType = "JL";
  SDM.issn_or_isbn = "13866532";
  SDM.sds = "2be97c8db67cbe02b5d0844e64ceaac4858eb2ec899ff6dd1fc3aff6fc3aeca5914e949244d1ea526dd25dc457c682d0";
  SDM.tid = "92595df4-bee2-11e2-9b7c-00000aab0f6b";
  SDM.ud = "103680|<SAInfo><SAId>17</SAId><SAName>IRELAND University Consortium</SAName><SANum>S000000017</SANum></SAInfo>|C000007922|14110|IPRANGE";
  SDM.pru = "http://pa.elsevier.com";
  SDM.crossMarkURL = "http://www.sciencedirect.com/science/crossMark";
  SDM.crossMarkLib = "http://crossmark.crossref.org/javascripts/crossmark.min.js";
 SDM.isCrossMark=false; 
  SDM.keOriginContentFamily = "serial"
  SDM.userActionURL = "http://www.sciencedirect.com/science/UserActions"
  SDM.sciverseUrlPfx="http://www.sciencedirect.com";
  SDM.sciverseJsonObject='';
  SDM.sciverseGadgetDetailsID = "ffe06e66-3aad-4e9d-a18f-eb6c43390367";
SDM.fullSize = true;
SDM.outlineGraphics = true;
SDM.outlineTab = "";
SDM.outlineImgFence = true;
SDM.entitled = true;
SDM.urlTOCLink="http://www.sciencedirect.com/science/article/pii/S138665320300115X";
SDM.urlTOCLinkQueryStr="?_rdoc=1&_fmt=full&_origin=&md5=22543fb95e34d36391c44b9d9cd72533";

SDM.displayGadgets=true;
SDM.euidCookieObject='72dbafc035ad07f02959a2cd1f930b3d6ff518d3a4c01778e60d26cb3ff7e2250083f2a03c2a3a53';

SDM.adArticleOptionsURL="/science/advertisement/options/num/485494/mainCat/general/cat/general/acct/caf12c083b5a42c1c4723593daa096bf/isn/13866532/doi/10.1016_S1386-6532(03)00115-X/page/article";
SDM.adArticleRightSmURL="";
SDM.adArticleRightLgURL="";
SDM.adReqOutline=false;
SDM.adReqOptions=false;
SDM.relatedRefAvail=true;
SDM.mlktAvail = true;
SDM.citedByScAvail = false;
SDM.crawlerAvail = false;
SDM.outwardLinks = '<div class="olLeftMiddle"><div class="boxLink"><a href="/science?_ob=RedirectURL&_method=outwardLink&_partnerName=19979&_eid=1-s2.0-S138665320300115X&_pii=S138665320300115X&_origin=article&_zone=rightPane&_targetURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS138665320300115X%3Fshowall%3Dtrue&_acct=C000007922&_version=1&_userid=103680&md5=0923d70c0f6eaee0f80e92b2d67183ef"  rel="nofollow" class="olSpawnWindow" target="outwardLink"><img src="http://www.sciencedirect.com.libgate.library.nuigalway.ie/scidirimg/gw_rtn_ihub.gif" alt="Get Full Text Elsewhere" title="Get Full Text Elsewhere" border="0"></a></div></div><div class="tableFmDivider">&nbsp;</div><div class="olLeftMiddle"><div class="boxLink"><a href="/science?_ob=RedirectURL&_method=outwardLink&_partnerName=254&_eid=1-s2.0-S138665320300115X&_pii=S138665320300115X&_origin=article&_zone=rightPane&_targetURL=http%3A%2F%2Fsfxhosted.exlibrisgroup.com%2Fgalway%3Fctx_ver%3DZ39.88-2004%26ctx_enc%3Dinfo%3Aofi%2Fenc%3AUTF-8%26url_ver%3DZ39.88-2004%26rfr_id%3Dinfo%3Asid%2FElsevier%3ASD%26svc_val_fmt%3Dinfo%3Aofi%2Ffmt%3Akev%3Amtx%3Asch_svc%26rft_val_fmt%3Dinfo%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal%26rft.aulast%3DKANTOR%26rft.auinit%3DR%26rft.date%3D2004%26rft.issn%3D13866532%26rft.volume%3D29%26rft.issue%3D3%26rft.spage%3D152%26rft.epage%3D159%26rft.title%3DJournal%2520of%2520Clinical%2520Virology%26rft.atitle%3DDrug%2520resistance%2520in%2520non-subtype%2520B%2520HIV-1%26rft_id%3Dinfo%3Adoi%2F10.1016%2FS1386-6532(03)00115-X&_acct=C000007922&_version=1&_userid=103680&md5=c8930b8a018c540c9531a202027bff5f"  rel="nofollow" class="olSpawnWindow" target="outwardLink"><img src="http://sfxhosted.exlibrisgroup.com.libgate.library.nuigalway.ie/galway/sfx.gif" alt="More related information in NUI, Galway" title="More related information in NUI, Galway" border="0"></a></div></div><div class="tableFmDivider">&nbsp;</div><div class="olLeftMiddle"><div class="boxLink"><a href="/science?_ob=RedirectURL&_method=outwardLink&_partnerName=5978&_eid=1-s2.0-S138665320300115X&_pii=S138665320300115X&_origin=article&_zone=rightPane&_targetURL=http%3A%2F%2Flinkinghub.pangaea.de%2Felsevier%2FredirectToSupplement%2F10.1016%2FS1386-6532(03)00115-X&_acct=C000007922&_version=1&_userid=103680&md5=1c48f1c4a314cb6a092c66f5d2f51b89"  rel="nofollow" class="olSpawnWindow" target="outwardLink"><img src="http://linkinghub.pangaea.de/elsevier/supplementBanner/10.1016/S1386-6532(03)00115-X" alt="PANGAEA Supplementary Data" title="PANGAEA Supplementary Data" border="0"></a></div></div><div class="olLeftMiddle"><div class="boxLink SC_record"><a href="/science?_ob=RedirectURL&_method=outwardLink&_partnerName=655&_eid=1-s2.0-S138665320300115X&_pii=S138665320300115X&_origin=article&_zone=rightPane&_targetURL=http%3A%2F%2Fwww.scopus.com%2Finward%2Frecord.url%3Feid%3D2-s2.0-1042287077%26partnerID%3D10%26rel%3DR3.0.0%26md5%3Dddb39c5b783104c61eea472474c03e14&_acct=C000007922&_version=1&_userid=103680&md5=fe11ea9ccab7ac8437acf8e0b6a5e19f"  rel="nofollow" class="olSpawnWindow" target="outwardLink">View Record in Scopus</a></div></div>';
   SDM.doi = '10.1016/S1386-6532(03)00115-X'; 
 SDM.isSpecialIssue=false; 
 SDM.hubEid = '1-s2.0-S1386653200X00546'; 


 SDM.relatedCitingPanelAvail = true; 
 SDM.applicationsPanelAvail=true; 
 SDM.rerunJson =''; 
 SDM.rerunAvail=true; 
 SDM.helpUrlDomain = "#";
 SDM.permAndReprint='<div class="boxLink"><a href="/science?_ob=RedirectURL&_method=outwardLink&_partnerName=936&_eid=1-s2.0-S138665320300115X&_pii=S138665320300115X&_origin=article&_zone=art_page&_targetURL=https%3A%2F%2Fs100.copyright.com%2FAppDispatchServlet%3FpublisherName%3DELS%26contentID%3DS138665320300115X%26orderBeanReset%3Dtrue&_acct=C000007922&_version=1&_userid=103680&md5=8d87be19a6195c13be6ef486ae73e501"  rel="nofollow" class="olSpawnWindow" target="outwardLink">Permissions & Reprints</a></div>'; 
 SDM.ppvMsg=''; 

SDM.ignoreForceAbst=false;
 
SDM.blk_all_social_logins='Y';

var googleAds = '';

SDM.svapi = SVApi;

</script>


<script>


initializeArticlePage();
</script>






<!-- START Nielsen Online SiteCensus V5.3 -->
<!-- COPYRIGHT 2009 Nielsen Online -->
<script type="text/javascript">

var _rsCI="us-sciencedirect";
var _rsCG="0";
var _rsDN="//secure-us.imrworldwide.com/";
var _rsPLfl=0;
</script>
<script type="text/javascript" src="v53.js"></script>
<noscript>

<div><img
src="//secure-us.imrworldwide.com/cgi-bin/m?ci=us-sciencedirect&amp;cg=0
&amp;cc=1" alt=""/></div>
</noscript>
<!-- END Nielsen Online SiteCensus V5.3 -->





<script>

  prs.rt('body_end');
  
</script>


<ul style="z-index: 62; display: none;" tabindex="0" id="ui-id-1" class="ui-autocomplete ui-menu ui-widget ui-widget-content ui-corner-all"></ul><script src="s_code_131.js"></script><img style="display: none;" src="pageReport"></body>
</html>
